Header Logo

JORGE CASTILLO

TitleAssistant Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
Address1504 TAUB LOOP
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Zanwar S, Abeykoon JP, D'Sa S, Roos-Weil D, Larson DR, Colby CL, Durot E, Kastritis E, Uppal E, Tomkins O, Morel P, Mondello P, Montes L, Paludo J, Ailawadhi S, Sarosiek S, Ogunbiyi O, Cornillet-Lefebvre P, Rajkumar SV, Quinquenel A, Dispenzieri A, Fonseca R, Gertz MA, Kumar SK, Dimopoulos MA, Ansell SM, Treon SP, Castillo JJ, Kapoor P, Zanwar S, Abeykoon J, D'Sa S, Roos-Weil D, Larson DR, Colby CL, Durot E, Kastritis E, Uppal E, Tomkins O, Morel P, Mondello P, Montes L, Paludo J, Ailawadhi S, Sarosiek S, Ogunbiyi O, Cornillet-Lefebvre P, Rajkumar SV, Quinquenel A, Dispenzieri A, Fonseca R, Gertz MA, Kumar S, Dimopoulos MA, Ansell SM, Treon S, Castillo JJ, Kapoor P. POD24 is a novel determinant of prognosis in patients with Waldenstr?m macroglobulinemia. Blood Adv. 2026 Apr 14; 10(7):2322-2327. PMID: 41499755.
      Citations:    Fields:    
    2. Tsakmaklis N, Hunter ZR, Liu X, Kofides A, Liu S, Guerrera ML, Guijosa A, Sun H, Hatcher JM, Peachey A, Patterson CJ, Meid K, Gustine J, Branagan AR, Sarosiek SR, Castillo JJ, Treon SP. Quantitative MYD88L265P and CXCR4S338X analysis to assess clinical trial performance in Waldenstrom macroglobulinemia. Blood Adv. 2026 Mar 24; 10(6):1954-1958. PMID: 41544209; PMCID: PMC12995488.
      Citations:    Fields:    
    3. Sun H, Sklavenitis Pistofidis R, Liu S, Liu X, Tsakmaklis N, Hatcher JM, Guerrera ML, Kofides A, Ramirez-Gamero AF, Peachey A, Li S, Keskin D, Chea V, Kim N, Lyu H, Lu W, Livak KJ, Meid KE, Guijosa A, Flynn C, Pizzarella D, Patterson CJ, Hao M, Yi S, Yuan W, Branagan AR, Wu CJ, Ghobrial IM, Qiu L, Sarosiek S, Castillo JJ, Hunter ZR, Treon SP. Evolution of tumor subclones and T-cell dynamics underlie variable ibrutinib responses in Waldenstr?m macroglobulinemia. Blood. 2026 Feb 11. PMID: 41671559.
      Citations:    Fields:    
    4. Ramirez-Gamero A, Tsakmaklis N, Hunter ZR, Guerrera ML, Guijosa A, Sarosiek S, Treon SP, Castillo JJ. Familial clusters and clinical features, complications, and outcomes in 1000 patients with Waldenstr?m macroglobulinemia. Blood Adv. 2026 Jan 27; 10(2):334-342. PMID: 41118612; PMCID: PMC12828760.
      Citations:    Fields:    Translation:Humans
    5. Sarosiek S, Castillo JJ, Hunter ZR, Branagan AR, Treon SP. Clinicopathological features and management of IgM multiple myeloma and Waldenstrom macroglobulinemia. Leuk Lymphoma. 2026 Jan 21; 1-8. PMID: 41566909.
      Citations:    Fields:    
    6. Hatcher JM, Liu S, Kofides A, Canning A, Pizzarella D, Liu X, Tsakmaklis N, Guerrera M, Patterson C, Guijosa A, Gokhale P, Hunter Z, Sarosiek S, Castillo J, Wang J, Buhrlage SJ, Treon SP. Discovery and Characterization of a First-In-Class HCK/BTK PROTAC DFCI-002-06 for the Treatment of MYD88 Mutated B Cell Malignancies. J Med Chem. 2026 Jan 22; 69(2):1119-1134. PMID: 41482966.
      Citations:    Fields:    Translation:HumansAnimalsCells
    7. Castillo JJ. When immature plasma cells form lymphoma: how to improve on diagnostics and treatment of plasmablastic lymphoma? Hematology Am Soc Hematol Educ Program. 2025 Dec 05; 2025(1):564-570. PMID: 41347973; PMCID: PMC12891359.
      Citations:    Fields:    Translation:HumansCells
    8. Guijosa A, Castillo JJ. Soluble BCMA: a window into tumor burden monitoring in Waldenstr?m macroglobulinemia? Leuk Lymphoma. 2026 Jan; 67(1):4-6. PMID: 41257442.
      Citations:    Fields:    
    9. Liu S, Kofides A, Liu X, Hatcher JM, Sun H, Tsakmaklis N, Guijosa A, Guerrera ML, Pizzarella D, Peachey AL, Patterson CJ, Hunter ZR, Meid K, Castillo JJ, Sarosiek SR, Treon SP. Repurposing pacritinib to target MYD88-mutated Waldenstr?m macroglobulinaemia. Br J Haematol. 2026 Feb; 208(2):727-731. PMID: 41255253; PMCID: PMC12645583.
      Citations:    Fields:    
    10. Pichardo-Rodriguez R, Vela-Ruiz JM, Villela L, Torres Viera MA, Beltran-Garate B, Ruiz-Franco O, Munayco-Guill?n F, Malpica L, Castillo JJ. Prognostic relevance of the neutrophil/lymphocyte ratio in diffuse large B-cell lymphoma: a systematic review and meta-analysis and dose-response evidence. Leuk Lymphoma. 2025 Dec; 66(14):2752-2764. PMID: 41143544.
      Citations:    Fields:    Translation:HumansCells
    11. Castillo JJ, Guijosa A, Allan JN, Siddiqi T, Advani RH, Flynn C, Meid KE, Budano N, Nguyen J, Ramirez-Gamero A, Tsakmaklis N, Hunter ZR, Patterson CJ, Treon SP, Sarosiek S, Castillo JJ, Guijosa A, Allan JN, Siddiqi T, Advani RH, Flynn CA, Meid K, Budano N, Nguyen J, Ramirez-Gamero A, Tsakmaklis N, Hunter ZR, Patterson CJ, Treon SP, Sarosiek S. Long-term follow-up of venetoclax monotherapy in previously treated patients with Waldenstr?m macroglobulinemia. Blood Adv. 2025 Oct 14; 9(19):4842-4847. PMID: 40674749; PMCID: PMC12495091.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    12. Guijosa A, Ramirez-Gamero A, Sarosiek S, Branagan AR, von Keudell G, Treon SP, Castillo JJ. Ibrutinib plus rituximab vs ibrutinib monotherapy in patients with Waldenstr?m macroglobulinemia: a pooled analysis. Blood Adv. 2025 Sep 23; 9(18):4705-4715. PMID: 40674744; PMCID: PMC12466266.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    13. Branagan AR, Mo C, Lei M, Gustine JN, Yee AJ, O'Donnell E, Castillo JJ, Nadeem O, Flynn C, Bernstein Z, Nakamoto-Matsubara R, Meid K, Verma R, Hunter ZR, Guerrera ML, Alter G, Burke J, Harrington C, Agyemang E, Gammon M, Lively K, Packer L, Horick N, Laubach J, Mitsiades CS, Munshi N, Anderson KC, Treon SP, Richardson PG, Raje NS, Sarosiek SR. Prospective study of immunogenicity to SARS-CoV-2 booster vaccines in multiple myeloma and Waldenstr?m macroglobulinemia. Blood Adv. 2025 Sep 23; 9(18):4568-4579. PMID: 40472329; PMCID: PMC12452669.
      Citations:    Fields:    Translation:Humans
    14. Guijosa A, Heras AL, Sarosiek S, Castillo JJ. SOHO State of the Art Updates and Next Questions | The Optimal Management of Waldenstr?m Macroglobulinemia. Clin Lymphoma Myeloma Leuk. 2026 Jan; 26(1):8-17. PMID: 40681432.
      Citations:    Fields:    Translation:Humans
    15. Bibas M, Antinori A, Mazzotta V, Marafioti T, Castillo JJ. The Genetic and Epigenetic Alterations of Plasmablastic Lymphoma: A Narrative Review. Cancers (Basel). 2025 Jun 09; 17(12). PMID: 40563566; PMCID: PMC12191365.
      Citations: 1     
    16. Treon SP, Sarosiek S, Castillo JJ. Diagnosis and Management of Waldenstrom's Macroglobulinemia. Hematol Oncol. 2025 Jun; 43 Suppl 2:e70071. PMID: 40517545.
      Citations:    Fields:    Translation:Humans
    17. Liu S, Liu X, Yusuf CFB, Kofides A, Soroko KM, Penailillo J, Canning AG, Cao Y, Yang G, Xu L, Tsakmaklis N, Sun H, Guijosa A, Guerrera ML, Patterson CJ, Carrasco RD, Gokhale PC, Sarosiek SR, Castillo JJ, Hatcher JM, Hunter ZR, Treon SP. Development and characterization of the novel MYD88 mutated, 6q deleted BCWM.2 cell line for Waldenstr?m macroglobulinaemia. Br J Haematol. 2025 Jun; 206(6):1604-1614. PMID: 40254718.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    18. Guijosa A, Sarosiek S, Castillo JJ. Current and emerging treatment perspectives for adults with Waldenstr?m macroglobulinemia. Expert Rev Anticancer Ther. 2025 May; 25(5):485-497. PMID: 40176471.
      Citations:    Fields:    Translation:Humans
    19. Paludo J, Abeykoon JP, Perera ND, Sarosiek S, Gustine J, Ramirez-Gamero A, Varettoni M, Tedeschi A, Cavalloni C, Frustaci AM, Pederson LD, Zanwar SS, Kapoor P, Habermann TM, Witzig TE, Kyle RA, Gertz MA, Geyer SM, Treon SP, Castillo JJ, Ansell SM. Depth of Response From Fixed-Duration Treatment Is Associated With Superior Survival in Waldenstrom Macroglobulinemia. Am J Hematol. 2025 Jun; 100(6):980-986. PMID: 40062689.
      Citations:    Fields:    Translation:Humans
    20. Valcarcel B, Schonfeld SJ, Shiels MS, Castillo JJ, Morton LM. Survival outcomes in diffuse large B-cell lymphoma patients with and without HIV in the United States from 2001 to 2016: a population-based analysis. Haematologica. 2025 Mar 01; 110(3):799-803. PMID: 39479866; PMCID: PMC11873710.
      Citations: 3     Fields:    
    21. Bibas M, Sarosiek S, Castillo JJ. Waldenstr?m Macroglobulinemia - A State-of-the-Art Review: Part 2- Focus on Therapy. Mediterr J Hematol Infect Dis. 2025; 17(1):e2025015. PMID: 40084099; PMCID: PMC11906134.
      Citations:    
    22. Heyman BM, Opat SS, Wahlin BE, Dimopoulos MC, Castillo JJ, Tedeschi A, Tam CS, Buske C, Owen RG, Leblond V, Trotman J, Barnes G, Chan WY, Schneider J, Allewelt H, Cohen A, Matous JV. Peripheral neuropathy in the phase 3 ASPEN study of Bruton tyrosine kinase inhibitors for Waldenstr?m macroglobulinemia. Blood Adv. 2025 Feb 25; 9(4):722-728. PMID: 39626287; PMCID: PMC11869863.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    23. Sarosiek S, Ramirez-Gamero A, Flynn CA, Treon SP, Castillo JJ. Zanubrutinib for the treatment of Bing-Neel syndrome. Br J Haematol. 2025 Apr; 206(4):1136-1140. PMID: 39967276.
      Citations: 2     Fields:    Translation:Humans
    24. Sarosiek S, Doughty CT, Castillo JJ. Monoclonal Gammopathy-Associated Neuropathy. Curr Hematol Malig Rep. 2024 Dec 16; 20(1):2. PMID: 39680359.
      Citations:    Fields:    Translation:Humans
    25. Durot E, Kanagaratnam L, Zanwar S, Kaufman A, D'Sa S, Toussaint E, Roos-Weil D, Alcoceba M, Vos JMI, Michallet AS, Talaulikar D, Kastritis E, Khwaja J, Treon SP, Garcia-Sanz R, Morel P, Munoz J, Castillo JJ, Kapoor P, Delmer A. Autologous and Allogeneic Stem-Cell Transplantation for Transformed Waldenstr?m Macroglobulinemia. Am J Hematol. 2025 Feb; 100(2):338-341. PMID: 39588555.
      Citations:    Fields:    
    26. Stanchina MD, Montoya S, Danilov AV, Castillo JJ, Alencar AJ, Chavez JC, Cheah CY, Chiattone C, Wang Y, Thompson M, Ghia P, Taylor J, Alderuccio JP. Navigating the changing landscape of BTK-targeted therapies for B cell lymphomas and chronic lymphocytic leukaemia. Nat Rev Clin Oncol. 2024 Dec; 21(12):867-887. PMID: 39487228.
      Citations: 7     Fields:    Translation:HumansCells
    27. Narasimhan S, Galetta KM, Castillo JJ, Bhattacharyya S. Paraneoplastic myelitis associated with Waldenstr?m macroglobulinemia responsive to treatment with ibrutinib - venetoclax: A case report. eNeurologicalSci. 2024 Dec; 37:100527. PMID: 39309451; PMCID: PMC11415854.
      Citations:    
    28. Cabrera ME, Pe?a C, Vega V, Rojas H, Pizarro A, Rojas C, Calderon S, Oliva J, Hales C, Rojas B, Intriago M, Capurro M, Gonzalez ML, Castillo JJ. Follicular Lymphoma in Chile in the Adult Public Cancer Program: The Impact of Chemoimmunotherapy. Cancer Rep (Hoboken). 2024 Sep; 7(9):e2126. PMID: 39307921; PMCID: PMC11416906.
      Citations:    Fields:    Translation:Humans
    29. Tedeschi A, Tam CS, Owen RG, Buske C, Leblond V, Dimopoulos M, Garcia-Sanz R, Castillo JJ, Trotman J, Treon SP, Yang K, Tang B, Allewelt H, Patel S, Chan WY, Cohen A, Chen S, Barnes G. Health-related quality of life in patients with Waldenstr?m macroglobulinemia: results from the ASPEN trial. Future Oncol. 2024; 20(25):1789-1798. PMID: 39072392; PMCID: PMC11485878.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    30. Malpica L, Marques-Piubelli ML, Beltran BE, Chavez JC, Miranda RN, Castillo JJ. EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2024 update on the diagnosis, risk-stratification, and management. Am J Hematol. 2024 Oct; 99(10):2002-2015. PMID: 38957951.
      Citations: 10     Fields:    Translation:HumansCells
    31. Bibas M, Sarosiek S, Castillo JJ. Waldenstr?m Macroglobulinemia - A State-of-the-Art Review: Part 1: Epidemiology, Pathogenesis, Clinicopathologic Characteristics, Differential Diagnosis, Risk Stratification, and Clinical Problems. Mediterr J Hematol Infect Dis. 2024; 16(1):e2024061. PMID: 38984103; PMCID: PMC11232678.
      Citations: 5     
    32. Zanwar S, Le-Rademacher J, Durot E, D'Sa S, Abeykoon JP, Mondello P, Kumar S, Sarosiek S, Paludo J, Chhabra S, Cook JM, Parrondo R, Dispenzieri A, Gonsalves WI, Muchtar E, Ailawadhi S, Kyle RA, Rajkumar SV, Delmer A, Fonseca R, Gertz MA, Treon SP, Ansell SM, Castillo JJ, Kapoor P. Simplified Risk Stratification Model for Patients With Waldenstr?m Macroglobulinemia. J Clin Oncol. 2024 Jul 20; 42(21):2527-2536. PMID: 38788183; PMCID: PMC11268554.
      Citations: 7     Fields:    Translation:Humans
    33. Ramirez-Gamero A, Mart?nez-Cordero H, Beltr?n BE, Florindez J, Malpica L, Castillo JJ. Plasmablastic lymphoma: 2024 update on diagnosis, risk stratification, and management. Am J Hematol. 2024 08; 99(8):1586-1594. PMID: 38767403.
      Citations: 19     Fields:    Translation:Humans
    34. Sarosiek S, Castillo JJ. Optimizing BTK Inhibition in Waldenstr?m Macroglobulinemia. J Natl Compr Canc Netw. 2024 05; 22(4). PMID: 38754469.
      Citations:    Fields:    Translation:Humans
    35. Treon SP, Sarosiek S, Castillo JJ. How I use genomics and BTK inhibitors in the treatment of Waldenstr?m macroglobulinemia. Blood. 2024 04 25; 143(17):1702-1712. PMID: 38211337; PMCID: PMC11103089.
      Citations: 6     Fields:    Translation:Humans
    36. Itchaki G, Jarhovsky O, Castillo JJ, Hassan H, Gatt ML, Leiba M, Raanani P, Gertz MA, Vaxman I. Lymphoplasmacytic lymphoma and multiple myeloma coexisting in the same patient: a case series and literature review. Leuk Lymphoma. 2024 Jul; 65(7):943-949. PMID: 38501758.
      Citations: 1     Fields:    Translation:Humans
    37. Castillo JJ, Branagan AR, Sermer D, Flynn CA, Meid K, Little M, Stockman K, White T, Canning A, Guerrera ML, Kofides A, Liu S, Liu X, Richardson K, Tsakmaklis N, Patterson CJ, Hunter ZR, Treon SP, Sarosiek S. Ibrutinib and venetoclax as primary therapy in symptomatic, treatment-na?ve Waldenstr?m macroglobulinemia. Blood. 2024 02 15; 143(7):582-591. PMID: 37971194; PMCID: PMC10873534.
      Citations:    
    38. Kumar SK, Callander NS, Adekola K, Anderson LD, Baljevic M, Baz R, Campagnaro E, Castillo JJ, Costello C, D'Angelo C, Derman B, Devarakonda S, Elsedawy N, Garfall A, Godby K, Hillengass J, Holmberg L, Htut M, Huff CA, Hultcrantz M, Kang Y, Larson S, Lee H, Liedtke M, Martin T, Omel J, Robinson T, Rosenberg A, Sborov D, Schroeder MA, Sherbenou D, Suvannasankha A, Valent J, Varshavsky-Yanovsky AN, Snedeker J, Kumar R. Waldenstr?m Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024 01; 22(1D):e240001. PMID: 38244272.
      Citations: 11     Fields:    Translation:Humans
    39. Sarosiek S, Castillo JJ. Waldenstr?m Macroglobulinemia: Targeted Agents Taking Center Stage. Drugs. 2024 Jan; 84(1):17-25. PMID: 38055179.
      Citations: 3     Fields:    Translation:Humans
    40. Kumar SK, Callander NS, Adekola K, Anderson LD, Baljevic M, Baz R, Campagnaro E, Castillo JJ, Costello C, D'Angelo C, Devarakonda S, Elsedawy N, Garfall A, Godby K, Hillengass J, Holmberg L, Htut M, Huff CA, Hultcrantz M, Kang Y, Larson S, Lee HC, Liedtke M, Martin T, Omel J, Robinson T, Rosenberg A, Sborov D, Schroeder MA, Sherbenou D, Suvannasankha A, Valent J, Varshavsky-Yanovsky AN, Kumar R, Snedeker J. Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023 12; 21(12):1281-1301. PMID: 38081133.
      Citations: 72     Fields:    Translation:Humans
    41. AlJabban A, Paik H, Aster JC, Berliner N, Brouillard J, Brown JR, Burns KH, Castillo JJ, Card J, Dal Cin P, DeAngelo DJ, Dorfman DM, Ebert BL, Garcia JS, Jacobson CA, Lakhani H, Laubach JP, Ligon AH, Lindeman NI, Lindsley RC, Lovitch SB, Luskin MR, Morgan EA, Nowak A, Petrides A, Pinkus GS, Pozdnyakova O, Steensma DP, Stone RM, Weinberg OK, Winer ES, Kim AS. Optimization of Advanced Molecular Genetic Testing Utilization in Hematopathology: A Goldilocks Approach to Bone Marrow Testing. JCO Oncol Pract. 2024 02; 20(2):220-227. PMID: 37683132.
      Citations:    Fields:    Translation:Humans
    42. Leung BW, Fay CJ, Said JT, Sheets AR, Lian CG, Brown JR, Castillo JJ, Sarosiek S, Flynn C, LeBoeuf NR. Localized upper extremity edema secondary to Bruton's tyrosine kinase inhibition. Leuk Lymphoma. 2023 12; 64(12):2047-2050. PMID: 37671695.
      Citations:    Fields:    Translation:Humans
    43. Dimopoulos MA, Opat S, D'Sa S, Jurczak W, Lee HP, Cull G, Owen RG, Marlton P, Wahlin BE, Garcia-Sanz R, McCarthy H, Mulligan S, Tedeschi A, Castillo JJ, Czyz J, Fern?ndez de Larrea C, Belada D, Libby E, Matous J, Motta M, Siddiqi T, Tani M, Trnen? M, Buske C, Leblond V, Treon SP, Trotman J, Chan WY, Schneider J, Allewelt H, Patel S, Cohen A, Tam CS, Minnema MC. Zanubrutinib Versus Ibrutinib in Symptomatic Waldenstr?m Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study. J Clin Oncol. 2023 11 20; 41(33):5099-5106. PMID: 37478390; PMCID: PMC10666987.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    44. Candelaria M, Villela L, Torres-Viera MA, Pe?a C, Roa M, Zambrano D, Colunga-Pedraza PRR, Robles-Rodr?guez A, P?rez-Jacobo F, Oliver AC, Irigo?n MV, Idrobo H, Paredes SR, Oliday R, Castro D, Monta?o-Figueroa E, Perini GF, Fern?ndez-Aguila JD, Malpica LE, Beltran BE, Castillo JJ, Baena R. Real-world experience in older patients with diffuse large B-cell lymphoma treated in Latin America: A study by the Latin American study group of lymphoproliferative disorders (GELL). J Geriatr Oncol. 2023 09; 14(7):101565. PMID: 37419788.
      Citations:    Fields:    Translation:Humans
    45. Sarosiek S, Treon SP, Branagan AR, Castillo JJ. Does Bortezomib-Dexamethasone-Rituximab-Cyclophosphamide Play a Role in the Treatment of Waldenstr?m's Macroglobulinemia? J Clin Oncol. 2023 08 20; 41(24):4059-4060. PMID: 37348023.
      Citations:    Fields:    Translation:Humans
    46. Talaulikar D, Tomowiak C, Toussaint E, Morel P, Kapoor P, Castillo JJ, Delmer A, Durot E. Evaluation and Management of Disease Transformation in Waldenstr?m Macroglobulinemia. Hematol Oncol Clin North Am. 2023 08; 37(4):787-799. PMID: 37246087.
      Citations:    
    47. Castillo JJ, Sarosiek S, Kapoor P. Waldenstr?m Macroglobulinemia: A Myriad of Effective Treatment Options, but Still Work to be Done. Hematol Oncol Clin North Am. 2023 08; 37(4):xiii-xiv. PMID: 37211493.
      Citations:    Fields:    Translation:Humans
    48. Sarosiek S, Castillo JJ. Novel Agents in Waldenstr?m Macroglobulinemia. Hematol Oncol Clin North Am. 2023 08; 37(4):751-760. PMID: 37198054.
      Citations: 2     Fields:    Translation:Humans
    49. Castro D, Valcarcel B, Runciman T, Huerta-Collado Y, Paredes S, Beltran BE, Castillo JJ, Malpica L. The prognostic role of red cell distribution width on all-cause and cause-specific outcomes in peripheral T-cell lymphoma: a retrospective cohort study. Leuk Lymphoma. 2023 Jul-Aug; 64(7):1225-1233. PMID: 37132428.
      Citations:    Fields:    
    50. Mu?oz J, Sarosiek S, Castillo JJ. Managing Ibrutinib-Intolerant Patients With B-Cell Malignancies. Oncologist. 2023 04 06; 28(4):309-318. PMID: 36723874; PMCID: PMC10078910.
      Citations:    
    51. de Lima M, Castillo J, Merli M, Garcia-Gutierrez V. Editorial: Epidemiological trends in hematological malignancies. Front Oncol. 2023; 13:1151774. PMID: 36865813; PMCID: PMC9972218.
      Citations:    
    52. Castillo JJ, Kingsley EC, Narang M, Yimer HA, Dasanu CA, Melear JM, Coleman M, Farber CM, Shulman J, Mantovani EH, Zhang X, Cohen A, Huang J. Zanubrutinib in patients with treatment-na?ve or relapsed/refractory Waldenstr?m macroglobulinemia: An expanded-access study of 50 patients in the United States. EJHaem. 2023 Feb; 4(1):301-304. PMID: 36819162; PMCID: PMC9928654.
      Citations:    
    53. Sarosiek S, Gustine JN, Flynn CA, Leventoff C, Little M, White T, Meid K, Treon SP, Castillo JJ. Dose reductions in patients with Waldenstr?m macroglobulinaemia treated with ibrutinib. Br J Haematol. 2023 06; 201(5):897-904. PMID: 36626914.
      Citations: 1     Fields:    Translation:Humans
    54. Castillo JJ, Buske C, Trotman J, Sarosiek S, Treon SP. Bruton tyrosine kinase inhibitors in the management of Waldenstr?m macroglobulinemia. Am J Hematol. 2023 02; 98(2):338-347. PMID: 36415104; PMCID: PMC10107762.
      Citations: 3     Fields:    Translation:Humans
    55. Hess BT, Giri A, Park Y, Patel KK, Link BK, Nowakowski GS, Maliske SM, Fortin S, Chavez JC, Saeed H, Hill BT, Mejia Garcia AV, Maddocks KJ, Hanel W, Wagner-Johnston ND, Messmer MR, Kahl BS, Watkins M, Alderuccio JP, Lossos IS, Nathan S, Orellana-Noia VM, Portell CA, Landsburg DJ, Ayers EC, Castillo JJ. Outcomes of patients with limited-stage plasmablastic lymphoma: A multi-institutional retrospective study. Am J Hematol. 2023 02; 98(2):300-308. PMID: 36588409; PMCID: PMC10107934.
      Citations: 2     Fields:    Translation:Humans
    56. Kumar SK, Callander NS, Adekola K, Anderson LD, Baljevic M, Campagnaro E, Castillo JJ, Costello C, D'Angelo C, Devarakonda S, Elsedawy N, Garfall A, Godby K, Hillengass J, Holmberg L, Htut M, Huff CA, Hultcrantz M, Kang Y, Larson S, Lee HC, Liedtke M, Martin T, Omel J, Rosenberg A, Sborov D, Valent J, Berardi R, Kumar R. Systemic Light Chain Amyloidosis, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023 01; 21(1):67-81. PMID: 36652935.
      Citations:    
    57. Cabrera ME, Pe?a C, Leon P, Lois V, Rojas H, Vega V, Pizarro A, Calderon S, Rojas C, Aspillaga A, Gonzalez ML, Intriago M, Rojas B, Hales C, Oliva J, Romero M, Capurro M, Castillo JJ. Diffuse Large B-Cell Lymphoma in Chile: The Impact of Combined CHOP Plus Rituximab in the Public Health System. JCO Glob Oncol. 2022 11; 8:e2200165. PMID: 36351213; PMCID: PMC10166504.
      Citations:    Fields:    Translation:HumansPHPublic Health
    58. Jelinek T, Bezdekova R, Zihala D, Sevcikova T, Anilkumar Sithara A, Pospisilova L, Sevcikova S, Polackova P, Stork M, Knechtova Z, Venglar O, Kapustova V, Popkova T, Muronova L, Chyra Z, Hrdinka M, Simicek M, Garc?s JJ, Puig N, Cedena MT, Jurczyszyn A, Castillo JJ, Penka M, Radocha J, Mateos MV, San-Miguel JF, Paiva B, Pour L, Rihova L, Hajek R. More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma. J Clin Oncol. 2023 03 01; 41(7):1383-1392. PMID: 36315921; PMCID: PMC9995102.
      Citations: 5     Fields:    Translation:HumansCells
    59. Mu?oz J, Paludo J, Sarosiek S, Castillo JJ. Coming of Age for BTK Inhibitor Therapy: A Review of Zanubrutinib in Waldenstr?m Macroglobulinemia. Cells. 2022 10 19; 11(20). PMID: 36291152; PMCID: PMC9600142.
      Citations:    
    60. Riva E, Duarte PJ, Valc?rcel B, Remaggi G, Murrieta I, Corzo A, Del Carpio D, Pe?a C, V?squez J, Bove V, Teixeira L, Fleury-Perini G, Yantorno S, Sam?nez C, Lopresti S, Altamirano M, Villela L, Ruiz-Arguelles GJ, Ruiz-Delgado GJ, Monta?o E, Verri V, Zamora P?rez E, P?rez Jacobo F, Idrobo H, Mart?nez-Cordero H, Beltran BE, Ram?rez J, Castillo JJ, Malpica Castillo LE. Treatment and Survival Outcomes of Waldenstrom Macroglobulinemia in Latin American Patients: A Multinational Retrospective Cohort Study. JCO Glob Oncol. 2022 08; 8:e2100380. PMID: 35939775; PMCID: PMC9470138.
      Citations:    
    61. Moreno DF, de Larrea CF, Castillo JJ. New treatment strategies for Waldenstr?m macroglobulinemia. Clin Adv Hematol Oncol. 2022 Aug; 20(8):506-515. PMID: 36125957.
      Citations:    
    62. Durot E, Kanagaratnam L, Zanwar S, Toussaint E, Kastritis E, D'Sa S, Alcoceba M, Tomowiak C, Hivert B, Protin C, Abeykoon JP, Vos JMI, Michallet AS, Rodier C, Dupuis J, Lepr?tre S, Merabet F, Roussel X, Zini JM, Regny C, Patel A, Morel P, Roos-Weil D, Treon SP, Dimopoulos MA, Garcia-Sanz R, Kapoor P, Castillo JJ, Delmer AJ. High frequency of central nervous system involvement in transformed Waldenstr?m macroglobulinemia. Blood Adv. 2022 06 28; 6(12):3655-3658. PMID: 35290439; PMCID: PMC9631579.
      Citations:    
    63. Munshi M, Liu X, Kofides A, Tsakmaklis N, Guerrera ML, Hunter ZR, Palomba ML, Argyropoulos KV, Patterson CJ, Canning AG, Meid K, Gustine J, Branagan AR, Flynn CA, Sarosiek S, Castillo JJ, Wang J, Buhrlage SJ, Gray NS, Munshi NC, Anderson KC, Treon SP, Yang G. A new role for the SRC family kinase HCK as a driver of SYK activation in MYD88 mutated lymphomas. Blood Adv. 2022 06 14; 6(11):3332-3338. PMID: 35255496; PMCID: PMC9198919.
      Citations:    
    64. Castillo JJ, Sarosiek S, Flynn CA, Leventoff C, Little M, White T, Meid K, Treon SP. A pilot study on dasatinib in patients with Waldenstr?m macroglobulinemia progressing on ibrutinib. EJHaem. 2022 Aug; 3(3):927-929. PMID: 36051045; PMCID: PMC9421949.
      Citations:    
    65. G?mez XE, Castillo JJ, G?mez MA. Bone marrow aspiration in a patient with systemic microsporidium. Clin Case Rep. 2022 May; 10(5):e05845. PMID: 35600011; PMCID: PMC9109649.
      Citations:    
    66. Dittus C, Miller JA, Wehbie R, Castillo JJ. Daratumumab with ifosfamide, carboplatin and etoposide for the treatment of relapsed plasmablastic lymphoma. Br J Haematol. 2022 07; 198(2):e32-e34. PMID: 35506301.
      Citations:    
    67. Malpica L, Marques-Piubelli ML, Beltran BE, Chavez JC, Miranda RN, Castillo JJ. EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2022 update on diagnosis, risk-stratification, and management. Am J Hematol. 2022 07; 97(7):951-965. PMID: 35472248.
      Citations:    Fields:    Translation:HumansCells
    68. Branagan AR, Gustine JN, Sarosiek S, Flynn CA, Meid K, Leventoff C, White T, Guerrera ML, Xu L, Kofides A, Tsakmaklis N, Munshi M, Demos M, Patterson CJ, Liu X, Yang G, Hunter ZR, Treon SP, Castillo JJ. Natural history of Waldenstr?m macroglobulinemia following acquired resistance to ibrutinib monotherapy. Haematologica. 2022 05 01; 107(5):1163-1171. PMID: 34162182; PMCID: PMC9052900.
      Citations:    Fields:    Translation:Humans
    69. Sermer D, Branagan AR, Sarosiek S, Treon SP, Castillo JJ. Zanubrutinib for the treatment of adults with Waldenstrom macroglobulinemia. Expert Rev Anticancer Ther. 2022 05; 22(5):471-478. PMID: 35404729.
      Citations:    Fields:    Translation:Humans
    70. Tahri S, Mouhieddine TH, Redd R, Lampe L, Nilsson KI, El-Khoury H, Su NK, Nassar AH, Adib E, Bindra G, Abou Alaiwi S, Trippa L, Steensma DP, Castillo JJ, Treon SP, Ghobrial IM, Sperling AS. Clonal hematopoiesis is associated with increased risk of progression of asymptomatic Waldenstr?m macroglobulinemia. Blood Adv. 2022 04 12; 6(7):2230-2235. PMID: 34847227; PMCID: PMC9006277.
      Citations:    Fields:    Translation:Humans
    71. Alderuccio JP, Arcaini L, Watkins MP, Beaven AW, Shouse G, Epperla N, Spina M, Stefanovic A, Sandoval-Sus J, Torka P, Alpert AB, Olszewski AJ, Kim SH, Hess B, Gaballa S, Ayyappan S, Castillo JJ, Voorhees TJ, Saba R, Chowdhury SM, Vargas F, Reis IM, Kwon D, Alexander JS, Zhao W, Edwards D, Martin P, Cencini E, Kamdar M, Link BK, Logothetis CN, Herrera AF, Friedberg JW, Kahl BS, Luminari S, Lossos IS, Argnani L, Zinzani PL. An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma. Blood Adv. 2022 04 12; 6(7):2035-2044. PMID: 35196377; PMCID: PMC9006265.
      Citations: 1     Fields:    Translation:Humans
    72. Derman B, Castillo JJ, Sarosiek S, Beksac M. When a Monoclonal Gammopathy Is Not Multiple Myeloma. Am Soc Clin Oncol Educ Book. 2022 Apr; 42:1-10. PMID: 35394823.
      Citations:    
    73. Sermer D, Sarosiek S, Branagan AR, Treon SP, Castillo JJ. SOHO State of the Art Updates and Next Questions: Targeted therapies and emerging novel treatment approaches for Waldenstr?m Macroglobulinemia. Clin Lymphoma Myeloma Leuk. 2022 08; 22(8):547-556. PMID: 35339405.
      Citations:    Fields:    Translation:Humans
    74. Castillo JJ. A British view on the management of Waldenstr?m macroglobulinemia. Br J Haematol. 2022 04; 197(2):133-134. PMID: 35138638.
      Citations:    Fields:    Translation:Humans
    75. Castillo JJ, Sarosiek SR, Gustine JN, Flynn CA, Leventoff CR, White TP, Meid K, Guerrera ML, Kofides A, Liu X, Munshi M, Tsakmaklis N, Hunter ZR, Patterson CJ, Branagan AR, Treon SP. Response and survival predictors in a cohort of 319 patients with Waldenstr?m macroglobulinemia treated with ibrutinib monotherapy. Blood Adv. 2022 02 08; 6(3):1015-1024. PMID: 34965304; PMCID: PMC8945307.
      Citations:    
    76. Mendoza R, Castro D, Paredes S, Miranda RN, Castillo JJ, Torres-Cabala C, Qui?ones MP, Beltr?n BE, Mois?s C, S?nchez G. Primary cutaneous Epstein-Barr virus-positive B-cell lymphoid proliferation with features of diffuse large B-cell lymphoma and mucocutaneous ulcer: a diagnostic dilemma. Int J Dermatol. 2023 02; 62(2):e87-e90. PMID: 35064673.
      Citations:    Fields:    
    77. Callander NS, Baljevic M, Adekola K, Anderson LD, Campagnaro E, Castillo JJ, Costello C, Devarakonda S, Elsedawy N, Faiman M, Garfall A, Godby K, Hillengass J, Holmberg L, Htut M, Huff CA, Hultcrantz M, Kang Y, Larson S, Liedtke M, Martin T, Omel J, Sborov D, Shain K, Stockerl-Goldstein K, Weber D, Berardi RA, Kumar R, Kumar SK. NCCN Guidelines? Insights: Multiple Myeloma, Version 3.2022. J Natl Compr Canc Netw. 2022 01; 20(1):8-19. PMID: 34991075.
      Citations: 1     Fields:    Translation:Humans
    78. Baljevic M, Sborov DW, Lim MY, Hillengass J, Martin T, Castillo JJ, Streiff MB, Kumar SK, Callander NS. Optimizing Thromboembolism Prophylaxis for the Contemporary Age of Multiple Myeloma. J Natl Compr Canc Netw. 2022 01; 20(1):91-95. PMID: 34991076.
      Citations:    
    79. Marinov N, Roa M, Castillo JJ, Matutes E, Cabrera ME. Epidemiology of chronic lymphocytic leukemia in Chilean and Amerindian population in Chile. Leuk Lymphoma. 2022 05; 63(5):1137-1143. PMID: 34886754.
      Citations:    Fields:    Translation:Humans
    80. Jalink M, Berentsen S, Castillo JJ, Treon SP, Cruijsen M, Fattizzo B, Cassin R, Fotiou D, Kastritis E, De Haas M, Oosten LEM, Frederiksen H, Patriarca A, D'Sa S, Vos JMI. Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease/cold agglutinin syndrome. Blood. 2021 11 18; 138(20):2002-2005. PMID: 34293088.
      Citations:    
    81. Allan JN, Siddiqi T, Advani RH, Branagan AR, Davids MS, Furman RR, Castillo JJ, Meid K, Leventoff C, White TP, Flynn CA, Sarosiek S, Demos MG, Guerrera ML, Kofides A, Liu X, Munshi M, Tsakmaklis N, Xu L, Yang G, Patterson CJ, Hunter ZR, Treon SP. Venetoclax in Previously Treated Waldenstr?m Macroglobulinemia. J Clin Oncol. 2022 01 01; 40(1):63-71. PMID: 34793256; PMCID: PMC8683218.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    82. Yang G, Wang J, Tan L, Munshi M, Liu X, Kofides A, Chen JG, Tsakmaklis N, Demos MG, Guerrera ML, Xu L, Hunter ZR, Che J, Patterson CJ, Meid K, Castillo JJ, Munshi NC, Anderson KC, Cameron M, Buhrlage SJ, Gray NS, Treon SP. The HCK/BTK inhibitor KIN-8194 is active in MYD88-driven lymphomas and overcomes mutated BTKCys481 ibrutinib resistance. Blood. 2021 11 18; 138(20):1966-1979. PMID: 34132782; PMCID: PMC8602936.
      Citations:    
    83. Durot E, Kanagaratnam L, Zanwar S, Kastritis E, D'Sa S, Garcia-Sanz R, Tomowiak C, Hivert B, Toussaint E, Protin C, Abeykoon JP, Guerrero-Garcia T, Itchaki G, Vos JM, Michallet AS, Godet S, Dupuis J, Lepr?tre S, Bomsztyk J, Morel P, Leblond V, Treon SP, Dimopoulos MA, Kapoor P, Delmer A, Castillo JJ. A prognostic index predicting survival in transformed Waldenstr?m macroglobulinemia. Haematologica. 2021 11 01; 106(11):2940-2946. PMID: 33179472; PMCID: PMC8561274.
      Citations:    
    84. Jurczyszyn A, Castillo JJ, Olszewska-Szopa M, Kumar L, Thibaud S, Richter J, Flicker K, Fiala M, Vij R, Yi S, Xu F, Silbermann R, Gaisan CM, Ocio EM, Waszczuk-Gajda A, Crusoe EQ, Salomon-Perzynski A, Hus I, Valls JD, Gozzetti A, Czepiel J, Krzanowska K, Chappell A, Chellapuram SK, Suska A, Vesole DH. POEMS Syndrome: Real World Experience in Diagnosis and Systemic Therapy - 108 Patients Multicenter Analysis. Clin Lymphoma Myeloma Leuk. 2022 05; 22(5):297-304. PMID: 34844892.
      Citations:    
    85. Treon SP, Meid K, Hunter ZR, Flynn CA, Sarosiek SR, Leventoff CR, White TP, Cao Y, Roccaro AM, Sacco A, Demos MG, Guerrera ML, Kofides A, Liu X, Xu L, Patterson CJ, Munshi M, Tsakmaklis N, Yang G, Ghobrial IM, Branagan AR, Castillo JJ. Phase 1 study of ibrutinib and the CXCR4 antagonist ulocuplumab in CXCR4-mutated Waldenstr?m macroglobulinemia. Blood. 2021 10 28; 138(17):1535-1539. PMID: 34289017; PMCID: PMC8786275.
      Citations:    
    86. Malpica L, Enriquez DJ, Idrobo H, Valcarcel B, Villela L, Ramos JC, Grupo de Estudio Latinoamericano de Linfoproliferativos (GELL), Castro D, Oviedo-Pecho R, Pe?a C, Fiad L, Prates M, Paredes A, S?nchez G, Mois?s C, Castillo JJ, Biglione M, Beltran BE. An international, multicenter, retrospective study on the positive impact of cutaneous involvement on the clinical outcome of adult T-cell leukemia/lymphoma. Leuk Lymphoma. 2022 02; 63(2):315-325. PMID: 34585997.
      Citations:    Fields:    Translation:HumansCells
    87. Branagan AR, O'Donnell E, Raje N, Yee AJ, Castillo JJ, Meid K, Gustine JN, Leventoff C, White T, Flynn CA, Sarosiek S, Demos MG, Guerrera ML, Kofides A, Liu X, Munshi M, Tsakmaklis N, Xu L, Yang G, Patterson CJ, Hunter ZR, Treon SP. Long-term follow-up of ibrutinib monotherapy in treatment-naive patients with Waldenstrom macroglobulinemia. Leukemia. 2022 02; 36(2):532-539. PMID: 34531537; PMCID: PMC8807393.
      Citations: 4     Fields:    Translation:Humans
    88. Sarosiek S, Treon SP, Castillo JJ. How to Sequence Therapies in Waldenstr?m Macroglobulinemia. Curr Treat Options Oncol. 2021 08 23; 22(10):92. PMID: 34426943.
      Citations: 2     Fields:    Translation:Humans
    89. LaMacchia J, Pozdnyakova O, Castillo JJ, Flynn CA, Sarosiek S, Treon SP. Plasmablastic lymphoma transformation in a patient with Waldenstr?m macroglobulinemia treated with ibrutinib. Br J Haematol. 2021 11; 195(3):466-468. PMID: 34355802.
      Citations:    Fields:    Translation:Humans
    90. Castillo JJ, Lamacchia J, Silver J, Flynn CA, Sarosiek S. Complete response to pembrolizumab and radiation in a patient with HIV-negative, EBV-positive plasmablastic lymphoma. Am J Hematol. 2021 10 01; 96(10):E390-E392. PMID: 34260089.
      Citations:    Fields:    Translation:HumansCells
    91. Branagan AR, Kofides A, Hunter ZR, Xu L, Tsakmaklis N, Demos MG, Munshi M, Liu X, Guerrera ML, Leventoff CR, White TP, Flynn CA, Meid K, Patterson CJ, Yang G, Sarosiek S, Castillo JJ, Treon SP, Gustine JN. Diagnostic Next-generation Sequencing Frequently Fails to Detect MYD88L265P in Waldenstr?m Macroglobulinemia. Hemasphere. 2021 Aug; 5(8):e624. PMID: 34291197; PMCID: PMC8288895.
      Citations: 3     
    92. Malpica L, Enriquez DJ, Idrobo H, Altamirano M, Sandival-Ampuero G, Aviles-Perez U, Meza K, Aguirre-Martinez L, Maradei JL, Soto P, Cabrera ME, Di Stefano M, Choque JA, Von Glasenapp A, Torres-Viera MA, Ramos JC, Villela L, Castro DA, Pe?a C, Fiad L, Prates M, Otero V, Biglione M, Cristaldo N, Guanchiale L, Vi?uela JL, Paredes SR, Riva E, Noboa A, Candelaria M, Valvert F, Castillo JJ, Beltran BE. Real-World Data on Adult T-Cell Leukemia/Lymphoma in Latin America: A Study From the Grupo de Estudio Latinoamericano de Linfoproliferativos. JCO Glob Oncol. 2021 07; 7:1151-1166. PMID: 34270330; PMCID: PMC8457808.
      Citations: 1     Fields:    Translation:Humans
    93. Castillo JJ, Beltran BE, Malpica L, Marques-Piubelli ML, Miranda RN. Anaplastic lymphoma kinase-positive large B-cell lymphoma (ALK?+?LBCL): a systematic review of clinicopathological features and management. Leuk Lymphoma. 2021 12; 62(12):2845-2853. PMID: 34151703.
      Citations:    Fields:    Translation:Humans
    94. Martz CA, Jarbeau JF, Castillo JJ, Fisher DC, Nohria A. Medical Management of Hemodynamically Unstable Sinoatrial Node Dysfunction in a Patient With Intracardiac Lymphoma. JACC CardioOncol. 2021 Jun; 3(2):326-329. PMID: 34396343; PMCID: PMC8352225.
      Citations:    
    95. Mozessohn L, Zhang L, Odejide OO, Chen R, Buckstein R, Soiffer RJ, Driver JA, Abel GA, Castillo JJ. Prognostic value of disease risk score versus gait speed in older adults with lymphoma. Leuk Lymphoma. 2021 12; 62(12):2882-2889. PMID: 34114930.
      Citations:    Fields:    Translation:Humans
    96. Branagan AR, Demos MG, Hunter ZR, Xu L, Tsakmaklis N, Kofides A, Munshi M, Liu X, Guerrera ML, Leventoff CR, White TP, Flynn CA, Meid K, Patterson CJ, Yang G, Sarosiek S, Castillo JJ, Treon SP, Gustine JN. Cell-free DNA analysis for detection of MYD88L265P and CXCR4S338X mutations in Waldenstr?m macroglobulinemia. Am J Hematol. 2021 07 01; 96(7):E250-E253. PMID: 33819355.
      Citations: 3     Fields:    Translation:Humans
    97. Castillo JJ, Callander NS, Baljevic M, Sborov DW, Kumar S. The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significance. Am J Hematol. 2021 07 01; 96(7):846-853. PMID: 33709474; PMCID: PMC8252623.
      Citations: 1     Fields:    Translation:HumansAnimals
    98. Branagan AR, Gustine JN, Xu L, Yang G, Liu X, Kofides A, Tsakmaklis N, Munshi M, Demos M, Guerrera ML, Meid K, Patterson CJ, Sarosiek S, Hunter ZR, Castillo JJ, Treon SP. Bone marrow involvement and subclonal diversity impairs detection of mutated CXCR4 by diagnostic next-generation sequencing in Waldenstr?m macroglobulinaemia. Br J Haematol. 2021 08; 194(4):730-733. PMID: 33713429; PMCID: PMC9113056.
      Citations: 4     Fields:    Translation:Humans
    99. Sarosiek S, Treon SP, Castillo JJ. Reducing treatment toxicity in Waldenstr?m macroglobulinemia. Expert Opin Drug Saf. 2021 Jun; 20(6):669-676. PMID: 33645373.
      Citations:    Fields:    Translation:Humans
    100. Branagan AR, Lei M, Treon SP, Castillo JJ. Clinical application of genomics in Waldenstr?m macroglobulinemia. Leuk Lymphoma. 2021 08; 62(8):1805-1815. PMID: 33569985.
      Citations:    Fields:    Translation:Humans
    101. Pachas C, Huerta Y, Lalupu K, Mendoza R, Castillo JJ, Castro D, Beltr?n B, Qui?ones MDP. Clinical, inflammatory and immunohistochemical features in a cohort of Peruvian patients with diffuse large B-cell lymphoma. Leuk Res. 2021 03; 102:106513. PMID: 33561632.
      Citations: 1     Fields:    Translation:Humans
    102. Castillo JJ, Treon SP. Management of Waldenstr?m macroglobulinemia in 2020. Hematology Am Soc Hematol Educ Program. 2020 12 04; 2020(1):372-379. PMID: 33275726; PMCID: PMC7727571.
      Citations: 6     Fields:    Translation:Humans
    103. Kumar SK, Callander NS, Adekola K, Anderson L, Baljevic M, Campagnaro E, Castillo JJ, Chandler JC, Costello C, Efebera Y, Faiman M, Garfall A, Godby K, Hillengass J, Holmberg L, Htut M, Huff CA, Kang Y, Hultcrantz M, Larson S, Liedtke M, Martin T, Omel J, Shain K, Sborov D, Stockerl-Goldstein K, Weber D, Keller J, Kumar R. Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020 12 02; 18(12):1685-1717. PMID: 33285522.
      Citations: 30     Fields:    Translation:HumansCells
    104. Jim?nez C, Xu L, Tsakmaklis N, Demos MG, Kofides A, Chan GG, Guerrera ML, Chen JG, Liu X, Munshi M, Patterson CJ, Yang G, Castillo JJ, Treon SP, Hunter ZR. Comparative genomics of CXCR4MUT and CXCR4WT single cells in Waldenstr?m's macroglobulinemia. Blood Adv. 2020 09 22; 4(18):4550-4553. PMID: 32956451; PMCID: PMC7509875.
      Citations: 2     Fields:    Translation:Humans
    105. Branagan AR, Palomba ML, Advani R, Treon SP, Meid K, Gustine J, Yang G, Xu L, Liu X, Patterson CJ, Hunter ZR, Laubach JP, Ghobrial IM, Castillo JJ. Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenstr?m Macroglobulinemia. J Clin Oncol. 2021 02 20; 39(6):565-575. PMID: 32931398; PMCID: PMC8078354.
      Citations: 29     Fields:    Translation:Humans
    106. Gabster A, Mayaud P, Ortiz A, Castillo J, Castillero O, Mart?nez A, L?pez A, Aizpr?a B, Pitano S, Murillo A, Pascale JM. Prevalence and determinants of genital Chlamydia trachomatis among school-going, sexually experienced adolescents in urban and rural Indigenous regions of Panama. Sex Transm Infect. 2021 06; 97(4):304-311. PMID: 32859684; PMCID: PMC8165139.
      Citations:    
    107. Castillo JJ, Meid K, Flynn CA, Chen J, Demos MG, Guerrera ML, Kofides A, Liu X, Munshi M, Tsakmaklis N, Patterson CJ, Yang G, Hunter Z, Treon SP. Ixazomib, dexamethasone, and rituximab in treatment-naive patients with Waldenstr?m macroglobulinemia: long-term follow-up. Blood Adv. 2020 08 25; 4(16):3952-3959. PMID: 32822482; PMCID: PMC7448596.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    108. Suska A, Vesole DH, Castillo JJ, Kumar SK, Parameswaran H, Mateos MV, Facon T, Gozzetti A, Mikala G, Szostek M, Mikhael J, Hajek R, Terpos E, Jurczyszyn A. Plasma Cell Leukemia - Facts and Controversies: More Questions than Answers? Clin Hematol Int. 2020 Dec; 2(4):133-142. PMID: 34595454; PMCID: PMC8432408.
      Citations:    
    109. Jurczyszyn A, Waszczuk-Gajda A, Castillo JJ, Krawczyk K, Stork M, Pour L, Usnarska-Zubkiewicz L, Potoczek S, Hus I, Davila Valls J, Hari P, Chhabra S, Gentile M, Mikala G, Varga G, Chim CS, Fiala M, Vij R, Schutz N, Rodzaj M, Porowska A, Vesole DH, Druzd-Sitek A, Walewski J, Nooka AK. Primary refractory multiple myeloma: a real-world experience with 85 cases. Leuk Lymphoma. 2020 12; 61(12):2868-2875. PMID: 32623944.
      Citations: 1     Fields:    Translation:Humans
    110. Aguilar C, Laberiano C, Beltran B, Diaz C, Castillo JJ, Taype-Rondan A. Clinicopathologic characteristics and survival of patients with primary effusion lymphoma. Leuk Lymphoma. 2020 09; 61(9):2093-2102. PMID: 32449626.
      Citations: 4     Fields:    Translation:HumansCells
    111. Castillo JJ, Gustine JN, Meid K, Flynn CA, Demos MG, Guerrera ML, Jimenez C, Kofides A, Liu X, Munshi M, Tsakmaklis N, Patterson CJ, Xu L, Yang G, Hunter ZR, Treon SP. Response and Survival Outcomes to Ibrutinib Monotherapy for Patients With Waldenstr?m Macroglobulinemia on and off Clinical Trials. Hemasphere. 2020 Jun; 4(3):e363. PMID: 32647793; PMCID: PMC7306303.
      Citations: 3     
    112. Treon SP, Castillo JJ, Skarbnik AP, Soumerai JD, Ghobrial IM, Guerrera ML, Meid K, Yang G. The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients. Blood. 2020 05 21; 135(21):1912-1915. PMID: 32302379; PMCID: PMC7243149.
      Citations: 131     Fields:    Translation:HumansCellsPHPublic Health
    113. Torres MA, Otero V, Fiad L, Cabrera ME, Idrobo H, Rojas C, Malpica L, Sotomayor EM, Castillo JJ, Latin American Group of Lymphoproliferative Disorders (Grupo de Estudio Latinoamericano de Linfoprol, Beltr?n BE, Villela L, Pe?a C, Le?n P, Castro DA, Paredes S, Perdomo I, Abello V, Ramirez-Ibarg?en A, Candelaria M, P?rez-Jacobo F, Monta?o-Figueroa E, Best C, Gom?z-De Leon A, G?mez-Almaguer D, Ruiz-Arg?elles G, Hern?ndez-Hern?ndez J. A Multi-Institutional Validation of the Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Patients With Diffuse Large B-Cell Lymphoma: A Study From The Latin American Group of Lymphoproliferative Disorders (GELL). Clin Lymphoma Myeloma Leuk. 2020 10; 20(10):637-646. PMID: 32513598.
      Citations: 1     Fields:    Translation:HumansCells
    114. Goldman-Mazur S, Jurczyszyn A, Castillo JJ, Waszczuk-Gajda A, Grzasko N, Radocha J, Gozzetti A, Usnarska-Zubkiewicz L, Valls JD, Jayabalan DS, Niesvizky R, Kelman J, Coriu D, Szukalski L, Jamroziak K, Hus I, Avivi I, Cohen Y, Mazur P, Suska A, Chappell A, Madduri D, Chhabra S, Kleman A, Hari P, Delforge M, Robak P, Gentile M, Kozlowska I, Goldberg SL, Czepiel J, Dlugosz-Danecka M, Silbermann R, Olszewski AJ, Barth P, Mikala G, Chim CS, Vesole DH, Bittrich M, Kort?m KM, Rosi?ol L, Gonz?lez-Calle V, Mateos MV. Different MAF translocations confer similar prognosis in newly diagnosed multiple myeloma patients. Leuk Lymphoma. 2020 08; 61(8):1885-1893. PMID: 32306794.
      Citations: 1     Fields:    Translation:Humans
    115. Beltran BE, Castro D, Paredes S, Miranda RN, Castillo JJ. EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2020 update on diagnosis, risk-stratification and management. Am J Hematol. 2020 04; 95(4):435-445. PMID: 32072672.
      Citations: 10     Fields:    Translation:HumansCells
    116. Goldman-Mazur S, Jurczyszyn A, Castillo JJ, Waszczuk-Gajda A, Grzasko N, Radocha J, Gozzetti A, Usnarska-Zubkiewicz L, Davila Valls J, Jayabalan DS, Niesvizky R, Kelman J, Coriu D, Szukalski L, Mateos MV, Jamroziak K, Hus I, Avivi I, Cohen Y, Suska A, Chappell A, Madduri D, Chhabra S, Kleman A, Hari P, Delforge M, Gentile M, Goldberg SL, Czepiel J, Silbermann R, Olszewski AJ, Barth P, Mikala G, Chim CS, Dlugosz-Danecka M, Grosicki S, Vesole DH, Bittrich M, Kort?m KM, Rosi?ol L, Gonz?lez-Calle V, Robak P, Kozlowska I. A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma. Am J Hematol. 2020 05; 95(5):503-509. PMID: 32072687.
      Citations: 4     Fields:    Translation:Humans
    117. Sklavenitis-Pistofidis R, Bustoros M, Sacco A, Roccaro A, Branagan AR, Ghobrial IM, Treon SP, Xu L, Guerrera ML, Jimenez C, Hunter ZR, Liu X, Demos M, Gustine J, Chan G, Munshi M, Tsakmaklis N, Chen JG, Kofides A, Keezer A, Meid K, Patterson CJ, Yang G, Castillo JJ. Genomic Landscape of Waldenstr?m Macroglobulinemia and Its Impact on Treatment Strategies. J Clin Oncol. 2020 04 10; 38(11):1198-1208. PMID: 32083995; PMCID: PMC7351339.
      Citations: 28     Fields:    Translation:Humans
    118. Munshi M, Liu X, Chen JG, Xu L, Tsakmaklis N, Demos MG, Kofides A, Guerrera ML, Jimenez C, Chan GG, Hunter ZR, Palomba ML, Argyropoulos KV, Meid K, Keezer A, Gustine J, Dubeau T, Castillo JJ, Patterson CJ, Wang J, Buhrlage SJ, Gray NS, Treon SP, Yang G. SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomas. Blood Cancer J. 2020 01 31; 10(1):12. PMID: 32005797; PMCID: PMC6994488.
      Citations: 13     Fields:    Translation:HumansCells
    119. Castillo JJ, Itchaki G, Gustine JN, Meid K, Flynn CA, Demos MG, Guerrera ML, Jimenez C, Kofides A, Liu X, Munshi M, Tsakmaklis N, Patterson CJ, Xu L, Yang G, Hunter ZR, Treon SP. A matched case-control study comparing features, treatment and outcomes between patients with non-IgM lymphoplasmacytic lymphoma and Waldenstr?m macroglobulinemia. Leuk Lymphoma. 2020 06; 61(6):1388-1394. PMID: 31992103.
      Citations: 2     Fields:    Translation:Humans
    120. Castillo JJ, Gustine JN, Meid K, Flynn CA, Demos MG, Guerrera ML, Jimenez C, Kofides A, Liu X, Munshi M, Tsakmaklis N, Patterson CJ, Xu L, Yang G, Hunter ZR, Treon SP. CXCR4 mutational status does not impact outcomes in patients with Waldenstr?m macroglobulinemia treated with proteasome inhibitors. Am J Hematol. 2020 04; 95(4):E95-E98. PMID: 31943341.
      Citations: 3     Fields:    Translation:Humans
    121. Borgna V, Lobos-Gonz?lez L, Guevara F, Landerer E, Bendek M, ?vila R, Silva V, Villota C, Araya M, Rivas A, L?pez C, Socias T, Castillo J, Alarc?n L, Burzio LO, Burzio VA, Villegas J. Targeting antisense mitochondrial noncoding RNAs induces bladder cancer cell death and inhibition of tumor growth through reduction of survival and invasion factors. J Cancer. 2020; 11(7):1780-1791. PMID: 32194789; PMCID: PMC7052861.
      Citations:    
    122. Liu X, Chen JG, Munshi M, Hunter ZR, Xu L, Kofides A, Tsakmaklis N, Demos MG, Guerrera ML, Chan GG, Jimenez C, Patterson CJ, Meid K, Keezer A, Castillo JJ, Treon SP, Yang G. Expression of the prosurvival kinase HCK requires PAX5 and mutated MYD88 signaling in MYD88-driven B-cell lymphomas. Blood Adv. 2020 01 14; 4(1):141-153. PMID: 31935288; PMCID: PMC6960458.
      Citations:    
    123. Castillo JJ, Gustine JN, Keezer A, Meid K, Flynn CA, Dubeau TE, Chan G, Chen J, Demos MG, Guerrera ML, Jimenez C, Kofides A, Liu X, Munshi M, Tsakmaklis N, Patterson CJ, Xu L, Yang G, Hunter ZR, Treon SP. Deepening of response after completing rituximab-containing therapy in patients with Waldenstrom macroglobulinemia. Am J Hematol. 2020 04; 95(4):372-378. PMID: 31868242.
      Citations:    Fields:    Translation:Humans
    124. Olszewski AJ, Butera JN, Reagan JL, Castillo JJ. Outcomes of bendamustine- or cyclophosphamide-based first-line chemotherapy in older patients with indolent B-cell lymphoma. Am J Hematol. 2020 04; 95(4):354-361. PMID: 31849108.
      Citations: 8     Fields:    Translation:Humans
    125. Gustine JN, Xu L, Tsakmaklis N, Demos MG, Kofides A, Chen JG, Liu X, Munshi M, Guerrera ML, Chan GG, Patterson CJ, Keezer A, Meid K, Dubeau T, Yang G, Hunter ZR, Treon SP, Castillo JJ. CXCR4S338X clonality is an important determinant of ibrutinib outcomes in patients with Waldenstr?m macroglobulinemia. Blood Adv. 2019 10 08; 3(19):2800-2803. PMID: 31570491; PMCID: PMC6784519.
      Citations:    
    126. Castillo JJ, Treon SP. What is new in the treatment of Waldenstrom macroglobulinemia? Leukemia. 2019 11; 33(11):2555-2562. PMID: 31591468.
      Citations: 6     Fields:    Translation:Humans
    127. Castillo JJ, Treon SP. How we manage Bing-Neel syndrome. Br J Haematol. 2019 11; 187(3):277-285. PMID: 31430829.
      Citations: 6     Fields:    Translation:Humans
    128. Bustoros M, Sklavenitis-Pistofidis R, Castillo JJ, Treon SP, Ghobrial IM. Reply to F.D. Leonard. J Clin Oncol. 2019 10 10; 37(29):2701-2702. PMID: 31424980.
      Citations:    Fields:    Translation:Humans
    129. Avivi I, Cohen YC, Suska A, Shragai T, Mikala G, Glickman S, Jayabalan DS, Niesvizky R, Gozzetti A, Wisniewska-Piaty K, Waszczuk-Gajda A, Usnarska-Zubkiewicz L, Hus I, Guzicka R, Radocha J, Milunovic V, Gentile M, Castillo JJ, Jurczyszyn A, Garderet L, Seny GM, Davila J. Hematogenous extramedullary relapse in multiple myeloma - a multicenter retrospective study in 127 patients. Am J Hematol. 2019 10; 94(10):1132-1140. PMID: 31334859.
      Citations: 9     Fields:    Translation:HumansCells
    130. Castillo JJ. HOLA! from Latin America to the myeloma world. Br J Haematol. 2020 02; 188(3):349-350. PMID: 31378927.
      Citations: 1     Fields:    Translation:Humans
    131. Castillo JJ, Xu L, Gustine JN, Keezer A, Meid K, Dubeau TE, Liu X, Demos MG, Kofides A, Tsakmaklis N, Chen JG, Munshi M, Guerrera ML, Chan GG, Patterson CJ, Yang G, Hunter ZR, Treon SP. CXCR4 mutation subtypes impact response and survival outcomes in patients with Waldenstr?m macroglobulinaemia treated with ibrutinib. Br J Haematol. 2019 11; 187(3):356-363. PMID: 31267520.
      Citations: 25     Fields:    Translation:Humans
    132. Treon SP, Hunter ZR, Branagan AR, Castillo JJ. Genomic landscape of Waldenstr?m's macroglobulinemia. Hemasphere. 2019 Jun; 3(Suppl). PMID: 35309816; PMCID: PMC8925683.
      Citations:    
    133. Paredes S, Castro D, Cotrina E, Sotomayor EM, Castillo JJ, Beltran BE. High Red Cell Distribution Width is an Adverse Predictive and Prognostic Factor in Patients With Diffuse Large B-Cell Lymphoma Treated With Chemoimmunotherapy. Clin Lymphoma Myeloma Leuk. 2019 09; 19(9):e551-e557. PMID: 31320254.
      Citations: 2     Fields:    Translation:Humans
    134. Castillo JJ, Ju?rez-Salcedo LM. Lymphoplasmacytic Lymphoma and Marginal Zone Lymphoma. Hematol Oncol Clin North Am. 2019 08; 33(4):639-656. PMID: 31229160.
      Citations: 4     Fields:    Translation:Humans
    135. Bustoros M, Sklavenitis-Pistofidis R, Kapoor P, Liu CJ, Kastritis E, Zanwar S, Fell G, Abeykoon JP, Hornburg K, Neuse CJ, Marinac CR, Liu D, Soiffer J, Gavriatopoulou M, Boehner C, Cappuccio JM, Dumke H, Reyes K, Soiffer RJ, Kyle RA, Treon SP, Castillo JJ, Dimopoulos MA, Ansell SM, Trippa L, Ghobrial IM. Progression Risk Stratification of Asymptomatic Waldenstr?m Macroglobulinemia. J Clin Oncol. 2019 06 01; 37(16):1403-1411. PMID: 30990729; PMCID: PMC6544461.
      Citations: 14     Fields:    Translation:Humans
    136. Paludo J, Varettoni M, Buske C, Eyre TA, Chavez JC, Shain KH, Issa S, Palomba ML, Pasvolsky O, Simpson D, Talaulikar D, Tam CS, Tedeschi A, Ansell SM, Nayak L, Castillo JJ, Itchaki G, Treon SP. Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study. Blood. 2019 01 24; 133(4):299-305. PMID: 30523119.
      Citations: 12     Fields:    Translation:Humans
    137. Cheng MP, Kusztos AE, Dryden-Peterson SL, Woolley AE, Hammond SP, Baden LR, Treon SP, Castillo JJ, Issa NC, Gustine JN, Dubeau TE. Low risk of Pneumocystis jirovecii pneumonia and invasive aspergillosis in patients with Waldenstr?m macroglobulinaemia on ibrutinib. Br J Haematol. 2019 05; 185(4):788-790. PMID: 30460682.
      Citations: 4     Fields:    Translation:HumansAnimals
    138. Barth P, Castillo JJ, Olszewski AJ. Outcomes of secondary solid tumor malignancies among patients with myeloma: A population-based study. Cancer. 2019 02 15; 125(4):550-558. PMID: 30452087.
      Citations: 1     Fields:    Translation:Humans
    139. Olszewski AJ, Castillo JJ. Ibrutinib and Rituximab in Waldenstr?m's Macroglobulinemia. N Engl J Med. 2018 11 15; 379(20):1973-4. PMID: 30439672.
      Citations: 1     Fields:    Translation:Humans
    140. Hunter ZR, Xu L, Tsakmaklis N, Demos MG, Kofides A, Jimenez C, Chan GG, Chen J, Liu X, Munshi M, Gustine J, Meid K, Patterson CJ, Yang G, Dubeau T, Samur MK, Castillo JJ, Anderson KC, Munshi NC, Treon SP. Insights into the genomic landscape of MYD88 wild-type Waldenstr?m macroglobulinemia. Blood Adv. 2018 11 13; 2(21):2937-2946. PMID: 30401751; PMCID: PMC6234368.
      Citations:    
    141. Babwah A, Gustine J, Meid K, Dubeau T, Xu L, Yang G, Hunter ZR, Treon SP, Castillo JJ. Long survival in patients with Waldenstr?m macroglobulinaemia diagnosed at a young age. Br J Haematol. 2019 05; 185(4):799-802. PMID: 30407630.
      Citations: 1     Fields:    Translation:Humans
    142. Sklavenitis-Pistofidis R, Capelletti M, Liu CJ, Reidy M, Zavidij O, Huynh D, Henrick P, Savell A, Reyes K, Rivotto B, Bustoros M, Perilla-Glen A, Trippa L, Castillo JJ, Treon SP, Ghobrial IM. Bortezomib overcomes the negative impact of CXCR4 mutations on survival of Waldenstrom macroglobulinemia patients. Blood. 2018 12 13; 132(24):2608-2612. PMID: 30366921; PMCID: PMC6293872.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    143. Bouyssou JM, Liu CJ, Bustoros M, Sklavenitis-Pistofidis R, Aljawai Y, Manier S, Yosef A, Sacco A, Kokubun K, Tsukamoto S, Perilla Glen A, Huynh D, Castillo JJ, Treon SP, Hermine O, Roccaro AM, Ghobrial IM, Capelletti M, Leblond V. Profiling of circulating exosomal miRNAs in patients with Waldenstr?m Macroglobulinemia. PLoS One. 2018; 13(10):e0204589. PMID: 30286096; PMCID: PMC6171840.
      Citations: 8     Fields:    Translation:HumansCells
    144. Kastritis E, Castillo JJ, Treon SP. Waldenstr?m Macroglobulinemia: Lessons Learned from Basic and Clinical Research. Hematol Oncol Clin North Am. 2018 10; 32(5):xiii-xiv. PMID: 30190026.
      Citations:    Fields:    Translation:Humans
    145. Gustine JN, Tsakmaklis N, Demos MG, Kofides A, Chen JG, Liu X, Munshi M, Guerrera ML, Chan GG, Patterson CJ, Meid K, Dubeau T, Yang G, Hunter ZR, Treon SP, Castillo JJ, Xu L. TP53 mutations are associated with mutated MYD88 and CXCR4, and confer an adverse outcome in Waldenstr?m macroglobulinaemia. Br J Haematol. 2019 01; 184(2):242-245. PMID: 30183082.
      Citations: 8     Fields:    Translation:Humans
    146. Jurczyszyn A, Castillo JJ, Vesole DH, Liu J, Avivi I, Waszczuk-Gajda A, Lech-Maranda E, Gentile M, Mikala G, Guerrero-Garcia T, Suska A, Gertz MA. Clinical characteristics and treatment outcomes in IgE multiple myeloma: A case-control study. Am J Hematol. 2018 09; 93(9):E238-E241. PMID: 29989240.
      Citations:    Fields:    Translation:Humans
    147. Treon SP, Gustine J, Meid K, Yang G, Xu L, Liu X, Demos M, Kofides A, Tsakmaklis N, Chen JG, Munshi M, Chan G, Dubeau T, Raje N, Yee A, O'Donnell E, Hunter ZR, Castillo JJ. Ibrutinib Monotherapy in Symptomatic, Treatment-Na?ve Patients With Waldenstr?m Macroglobulinemia. J Clin Oncol. 2018 09 20; 36(27):2755-2761. PMID: 30044692.
      Citations: 53     Fields:    Translation:HumansCTClinical Trials
    148. Treon SP, Xu L, Liu X, Hunter ZR, Yang G, Castillo JJ. Genomic Landscape of Waldenstr?m Macroglobulinemia. Hematol Oncol Clin North Am. 2018 10; 32(5):745-752. PMID: 30190014.
      Citations: 2     Fields:    Translation:HumansCells
    149. Castillo JJ, Treon SP. Initial Evaluation of the Patient with Waldenstr?m Macroglobulinemia. Hematol Oncol Clin North Am. 2018 10; 32(5):811-820. PMID: 30190019.
      Citations: 4     Fields:    Translation:Humans
    150. Jurczyszyn A, Davila J, Jayabalan DS, Vij R, Fiala M, Milunovic V, Chim CS, Wisniewska-Piaty K, Waszczuk-Gajda A, Crusoe E, Hajek R, Robak P, Razny M, Zawirska D, Nahi H, Liu J, Castillo JJ, Vesole DH, Kort?m KM, Bittrich M. Multiple myeloma in patients up to 30?years of age: a multicenter retrospective study of 52 cases. Leuk Lymphoma. 2019 02; 60(2):471-476. PMID: 30033832.
      Citations: 5     Fields:    Translation:Humans
    151. Dominguez A, Kastritis E, Castillo JJ. Monoclonal Antibodies for Waldenstr?m Macroglobulinemia. Hematol Oncol Clin North Am. 2018 Oct; 32(5):841-852. PMID: 30190022.
      Citations:    
    152. Jurczyszyn A, Castillo JJ, Avivi I, Czepiel J, Davila J, Vij R, Fiala MA, Gozzetti A, Grzasko N, Milunovic V, Hus I, Madry K, Waszczuk-Gajda A, Usnarska-Zubkiewicz L, Debski J, Atilla E, Beksac M, Mele G, Sawicki W, Jayabalan D, Charlinski G, Gyula Szabo A, Hajek R, Delforge M, Fantl D, Waage A, Crusoe E, Hungria V, Richardson P, Laubach J, Guerrero-Garcia T, Liu J, Vesole DH, Kopacz A. Secondary plasma cell leukemia: a multicenter retrospective study of 101 patients. Leuk Lymphoma. 2019 01; 60(1):118-123. PMID: 29965787.
      Citations: 7     Fields:    Translation:Humans
    153. Castillo JJ, Beltran BE, Miranda RN, Young KH, Chavez JC, Sotomayor EM. EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2018 update on diagnosis, risk-stratification and management. Am J Hematol. 2018 07; 93(7):953-962. PMID: 29984868.
      Citations: 26     Fields:    Translation:HumansCells
    154. Treon SP, Castillo JJ. The real world of Waldenstr?m's macroglobulinaemia. Lancet Haematol. 2018 07; 5(7):e275-e276. PMID: 29958567.
      Citations: 2     Fields:    Translation:Humans
    155. Castillo JJ. Viral lymphomagenesis: beyond the usual suspects. Br J Haematol. 2018 09; 182(5):617-618. PMID: 29808932.
      Citations:    Fields:    Translation:HumansCells
    156. Castillo JJ, Gustine JN, Meid K, Dubeau TE, Xu L, Yang G, Hunter ZR, Advani R, Palomba L, Treon SP. Impact of ibrutinib dose intensity on patient outcomes in previously treated Waldenstr?m macroglobulinemia. Haematologica. 2018 10; 103(10):e466-e468. PMID: 29773590; PMCID: PMC6165799.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    157. Castillo JJ, Dubeau T, Kofides A, Demos MG, Tsakmaklis N, Xu L, Hunter ZR, Treon SP. Spotting the elusive Siberian tiger: Complete response to ibrutinib in a patient with Waldenstr?m Macroglobulinemia. Am J Hematol. 2018 May 14. PMID: 29756293.
      Citations: 1     Fields:    
    158. Castillo JJ, Gustine JN, Treon SP. Fitting mSMART Into the Current Clinical Management of Waldenstr?m Macroglobulinemia. JAMA Oncol. 2018 05 01; 4(5):744-745. PMID: 29392274.
      Citations:    Fields:    Translation:Humans
    159. Singh A, Geller HI, Alexander KM, Padera RF, Mitchell RN, Dorbala S, Castillo JJ, Falk RH. True, true unrelated? Coexistence of Waldenstr?m macroglobulinemia and cardiac transthyretin amyloidosis. Haematologica. 2018 08; 103(8):e374-e376. PMID: 29674499; PMCID: PMC6068030.
      Citations: 1     Fields:    Translation:Humans
    160. Castillo JJ, Meid K, Gustine JN, Dubeau T, Severns P, Hunter ZR, Yang G, Xu L, Treon SP. Prospective Clinical Trial of Ixazomib, Dexamethasone, and Rituximab as Primary Therapy in Waldenstr?m Macroglobulinemia. Clin Cancer Res. 2018 07 15; 24(14):3247-3252. PMID: 29661775.
      Citations:    
    161. Guerrera ML, Tsakmaklis N, Xu L, Yang G, Demos M, Kofides A, Chan GG, Manning RJ, Liu X, Chen JG, Munshi M, Patterson CJ, Castillo JJ, Dubeau T, Gustine J, Carrasco RD, Arcaini L, Varettoni M, Cazzola M, Treon SP, Hunter ZR. MYD88 mutated and wild-type Waldenstr?m's Macroglobulinemia: characterization of chromosome 6q gene losses and their mutual exclusivity with mutations in CXCR4. Haematologica. 2018 09; 103(9):e408-e411. PMID: 29599202; PMCID: PMC6119142.
      Citations:    
    162. Castillo JJ, Gustine JN, Meid K, Dubeau T, Severns P, Xu L, Yang G, Hunter ZR, Treon SP. Low levels of von Willebrand markers associate with high serum IgM levels and improve with response to therapy, in patients with Waldenstr?m macroglobulinaemia. Br J Haematol. 2019 03; 184(6):1011-1014. PMID: 29532913.
      Citations: 6     Fields:    Translation:Humans
    163. Chen JG, Liu X, Munshi M, Xu L, Tsakmaklis N, Demos MG, Kofides A, Guerrera ML, Chan GG, Patterson CJ, Meid K, Gustine J, Dubeau T, Severns P, Castillo JJ, Hunter ZR, Wang J, Buhrlage SJ, Gray NS, Treon SP, Yang G. BTKCys481Ser drives ibrutinib resistance via ERK1/2 and protects BTKwild-type MYD88-mutated cells by a paracrine mechanism. Blood. 2018 05 03; 131(18):2047-2059. PMID: 29496671.
      Citations:    
    164. Beltran BE, Castro D, De La Cruz-Vargas JA, Cotrina E, Gallo A, Sotomayor EM, Castillo JJ. The neutrophil-lymphocyte ratio is prognostic in patients with early stage aggressive peripheral T cell lymphoma. Br J Haematol. 2019 02; 184(4):650-653. PMID: 29479670.
      Citations: 3     Fields:    Translation:HumansCellsCTClinical Trials
    165. Castillo JJ, Gustine JN, Meid K, Dubeau TE, Severns P, Xu L, Yang G, Hunter ZR, Treon SP. Response and survival for primary therapy combination regimens and maintenance rituximab in Waldenstr?m macroglobulinaemia. Br J Haematol. 2018 04; 181(1):77-85. PMID: 29468652.
      Citations: 11     Fields:    Translation:Humans
    166. Castillo JJ, Gustine JN, Meid K, Dubeau T, Severns P, Treon SP. Ibrutinib withdrawal symptoms in patients with Waldenstr?m macroglobulinemia. Haematologica. 2018 07; 103(7):e307-e310. PMID: 29472352; PMCID: PMC6029546.
      Citations: 13     Fields:    Translation:Humans
    167. Paredes S, Cotrina E, Sotomayor EM, Castillo JJ, Beltr?n BE. The impact of the neutrophil:lymphocyte ratio in response and survival of patients with de novo diffuse large B-cell lymphoma. Leuk Res. 2018 04; 67:82-85. PMID: 29477024.
      Citations: 2     Fields:    Translation:HumansCells
    168. Gustine JN, Meid K, Dubeau T, Severns P, Hunter ZR, Guang Y, Xu L, Treon SP, Castillo JJ. Ibrutinib discontinuation in Waldenstr?m macroglobulinemia: Etiologies, outcomes, and IgM rebound. Am J Hematol. 2018 08; 93(4):511-517. PMID: 29280186.
      Citations: 16     Fields:    Translation:Humans
    169. Jurczyszyn A, Radocha J, Davila J, Fiala MA, Gozzetti A, Grzasko N, Hus I, Waszczuk-Gajda A, Guzicka-Kazimierczak R, Atilla E, Mele G, Sawicki W, Jayabalan DS, Charlinski G, Hajek R, Delforge M, Fantl D, Waage A, Avivi I, Rodzaj M, Leleu X, Richez V, Knopinska-Posluszny W, Masternak A, Yee AJ, Barchnicka A, Druzd-Sitek A, Guerrero-Garcia T, Liu J, Vesole DH, Castillo JJ, Robak P, Szabo AG, Kopacz A. Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients. Br J Haematol. 2018 03; 180(6):831-839. PMID: 29315478.
      Citations: 17     Fields:    Translation:HumansCTClinical Trials
    170. L?pez-Jaramillo P, Calder?n C, Castillo J, Escobar ID, Melgarejo E, Parra GA. Prediabetes in Colombia: Expert Consensus. Colomb Med (Cali). 2017 Dec 30; 48(4):191-203. PMID: 29662261; PMCID: PMC5896726.
      Citations:    
    171. Castillo JJ, Gustine JN, Meid K, Xu L, Hunter ZR, Treon SP. Comparing apples to oranges: A commentary on the Mayo study of MYD88 significance in Waldenstrom's macroglobulinemia. Am J Hematol. 2018 03; 93(3):E69-E71. PMID: 29218718.
      Citations:    Fields:    Translation:Humans
    172. Castillo JJ, Treon SP. Toward personalized treatment in Waldenstr?m macroglobulinemia. Hematology Am Soc Hematol Educ Program. 2017 12 08; 2017(1):365-370. PMID: 29222280; PMCID: PMC6142554.
      Citations: 1     Fields:    Translation:Humans
    173. Treon SP, Castillo JJ. What should be the goal of therapy for Waldenstr?m macroglobulinemia patients? Complete response should be the goal of therapy. Blood Adv. 2017 Nov 28; 1(25):2486-2490. PMID: 29296899; PMCID: PMC5729614.
      Citations: 2     Fields:    
    174. Treon SP, Gustine J, Xu L, Manning RJ, Tsakmaklis N, Demos M, Meid K, Guerrera ML, Munshi M, Chan G, Chen J, Kofides A, Patterson CJ, Yang G, Liu X, Severns P, Dubeau T, Hunter ZR, Castillo JJ. MYD88 wild-type Waldenstrom Macroglobulinaemia: differential diagnosis, risk of histological transformation, and?overall survival. Br J Haematol. 2018 02; 180(3):374-380. PMID: 29181840.
      Citations: 25     Fields:    Translation:Humans
    175. Beltran BE, Sanchez G, Paredes A, Moises C, Cotrina E, Torres-Cabala CA, Miranda RN, Castillo JJ, Qui?ones P. Primary cutaneous plasmablastic lymphoma in an immunocompetent patient: is it associated with an indolent course? Leuk Lymphoma. 2018 07; 59(7):1753-1755. PMID: 29081245.
      Citations: 2     Fields:    Translation:Humans
    176. Olszewski AJ, Reagan JL, Castillo JJ. Late infections and secondary malignancies after bendamustine/rituximab or RCHOP/RCVP chemotherapy for B-cell lymphomas. Am J Hematol. 2018 01; 93(1):E1-E3. PMID: 28960532.
      Citations: 7     Fields:    Translation:Humans
    177. Qunaj L, Castillo JJ, Olszewski AJ. Survival of patients with CD20-negative variants of large B-cell lymphoma: an analysis of the National Cancer Data Base. Leuk Lymphoma. 2018 06; 59(6):1375-1383. PMID: 29019447.
      Citations: 10     Fields:    Translation:HumansPHPublic Health
    178. Guerrero-Garcia TA, Mogollon RJ, Castillo JJ. Bortezomib in plasmablastic lymphoma: A glimpse of hope for a hard-to-treat disease. Leuk Res. 2017 11; 62:12-16. PMID: 28963907.
      Citations: 16     Fields:    Translation:Humans
    179. Vos JM, Tsakmaklis N, Patterson CJ, Meid K, Castillo JJ, Brodsky P, Ganz T, Pals ST, Kersten MJ, Xu L, Yang G, Treon SP, Hunter ZR. CXCL13 levels are elevated in patients with Waldenstr?m macroglobulinemia, and are predictive of major response to ibrutinib. Haematologica. 2017 11; 102(11):e452-e455. PMID: 28798070; PMCID: PMC5664407.
      Citations:    
    180. Gozzetti A, Vij R, Fiala M, Valls DJ, Madry K, Waszczuk-Gajda A, Grosicki S, Barchnicka A, Crusoe E, Hungria V, Gentile M, Mele G, Ksieniewicz M, Vesole DH, Castillo JJ, Jurczyszyn A, Gdula-Argasinska J, Czepiel J. Similar survival outcomes in patients with biclonal versus monoclonal myeloma: a multi-institutional matched case-control study. Ann Hematol. 2017 Oct; 96(10):1693-1698. PMID: 28766002.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    181. Olszewski AJ, Chen C, Gutman R, Treon SP, Castillo JJ. Comparative outcomes of immunochemotherapy regimens in Waldenstr?m macroglobulinaemia. Br J Haematol. 2017 10; 179(1):106-115. PMID: 28677830.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    182. Castillo JJ, Hunter ZR, Yang G, Treon SP. Novel approaches to targeting MYD88 in Waldenstr?m macroglobulinemia. Expert Rev Hematol. 2017 08; 10(8):739-744. PMID: 28617062.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    183. Beltran BE, Morales D, Malaga JM, Chavez JC, Sotomayor EM, Castillo JJ, Qui?ones P. Response and survival benefit with chemoimmunotherapy in Epstein-Barr virus-positive diffuse large B-cell lymphoma. Hematol Oncol. 2018 Feb; 36(1):93-97. PMID: 28639256.
      Citations: 8     Fields:    Translation:Humans
    184. Castillo JJ, Jurczyszyn A, Brozova L, Crusoe E, Czepiel J, Davila J, Dispenzieri A, Eveillard M, Fiala MA, Ghobrial IM, Gozzetti A, Gustine JN, Hajek R, Hungria V, Jarkovsky J, Jayabalan D, Laubach JP, Lewicka B, Maisnar V, Manasanch EE, Moreau P, Morgan EA, Nahi H, Niesvizky R, Paba-Prada C, Pika T, Pour L, Reagan JL, Richardson PG, Shah J, Spicka I, Vij R, Waszczuk-Gajda A, Gertz MA. IgM myeloma: A multicenter retrospective study of 134 patients. Am J Hematol. 2017 Aug; 92(8):746-751. PMID: 28383205.
      Citations: 12     Fields:    Translation:HumansCells
    185. Gustine JN, Meid K, Dubeau T, Hunter ZR, Xu L, Yang G, Ghobrial IM, Treon SP, Castillo JJ. Serum IgM level as predictor of symptomatic hyperviscosity in patients with Waldenstr?m macroglobulinaemia. Br J Haematol. 2017 06; 177(5):717-725. PMID: 28485115.
      Citations: 12     Fields:    Translation:Humans
    186. Xu L, Tsakmaklis N, Yang G, Chen JG, Liu X, Demos M, Kofides A, Patterson CJ, Meid K, Gustine J, Dubeau T, Palomba ML, Advani R, Castillo JJ, Furman RR, Hunter ZR, Treon SP. Acquired mutations associated with ibrutinib resistance in Waldenstr?m macroglobulinemia. Blood. 2017 05 04; 129(18):2519-2525. PMID: 28235842; PMCID: PMC7484977.
      Citations:    
    187. D'Sa S, Kersten MJ, Castillo JJ, Dimopoulos M, Kastritis E, Laane E, Leblond V, Merlini G, Treon SP, Vos JM, Lunn MP. Investigation and management of IgM and Waldenstr?m-associated peripheral neuropathies: recommendations from the IWWM-8 consensus panel. Br J Haematol. 2017 03; 176(5):728-742. PMID: 28198999.
      Citations:    
    188. Hunter ZR, Yang G, Xu L, Liu X, Castillo JJ, Treon SP. Genomics, Signaling, and Treatment of Waldenstr?m Macroglobulinemia. J Clin Oncol. 2017 Mar 20; 35(9):994-1001. PMID: 28294689.
      Citations: 29     Fields:    Translation:HumansCells
    189. Treon SP, Meid K, Tripsas C, Heffner LT, Eradat H, Badros AZ, Xu L, Hunter ZR, Yang G, Patterson CJ, Gustine J, Castillo JJ, Matous J, Ghobrial IM. Prospective, Multicenter Clinical Trial of Everolimus as Primary Therapy in Waldenstrom Macroglobulinemia (WMCTG 09-214). Clin Cancer Res. 2017 May 15; 23(10):2400-2404. PMID: 27836860.
      Citations: 4     Fields:    Translation:HumansCellsCTClinical Trials
    190. Gustine JN, Meid K, Hunter ZR, Xu L, Treon SP, Castillo JJ. MYD88 mutations can be used to identify malignant pleural effusions in Waldenstr?m macroglobulinaemia. Br J Haematol. 2018 02; 180(4):578-581. PMID: 27748515.
      Citations: 7     Fields:    Translation:Humans
    191. Castillo JJ. Plasma Cell Disorders. Prim Care. 2016 Dec; 43(4):677-691. PMID: 27866585.
      Citations: 5     Fields:    Translation:HumansCells
    192. Minnema MC, Kimby E, D'Sa S, Fornecker LM, Poulain S, Snijders TJ, Kastritis E, Kremer S, Fitsiori A, Simon L, Davi F, Lunn M, Castillo JJ, Patterson CJ, Le Garff-Tavernier M, Costopoulos M, Leblond V, Kersten MJ, Dimopoulos MA, Treon SP. Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome. Haematologica. 2017 01; 102(1):43-51. PMID: 27758817; PMCID: PMC5210231.
      Citations:    
    193. Jurczyszyn A, Nahi H, Avivi I, Gozzetti A, Niesvizky R, Yadlapati S, Jayabalan DS, Robak P, Pika T, Andersen KT, Rasche L, Madry K, Woszczyk D, Razny M, Usnarska-Zubkiewicz L, Knopinska-Posluszny W, Wojciechowska M, Guzicka-Kazimierczak R, Joks M, Grosicki S, Ciepluch H, Rymko M, Vesole DH, Castillo JJ. Characteristics and outcomes of patients with multiple myeloma aged 21-40?years versus 41-60?years: a multi-institutional case-control study. Br J Haematol. 2016 Dec; 175(5):884-891. PMID: 27682187.
      Citations:    
    194. Argyropoulos K, Palomba ML, Castillo JJ, Hunter ZR, Yang G, Treon SP. Future therapeutic options for patients with Waldenstr?m macroglobulinemia. Best Pract Res Clin Haematol. 2016 06; 29(2):206-215. PMID: 27825467.
      Citations: 2     Fields:    Translation:Humans
    195. Castillo JJ. Risk factors for progression from smoldering into active myeloma: additional insights from a population-based study. Eur J Haematol. 2016 Sep; 97(3):217-8. PMID: 26918423.
      Citations:    Fields:    Translation:HumansPHPublic Health
    196. Olszewski AJ, Mantripragada KC, Castillo JJ. Risk Factors for Early Death After Rituximab-Based Immunochemotherapy in Older Patients With Diffuse Large B-Cell Lymphoma. J Natl Compr Canc Netw. 2016 09; 14(9):1121-9. PMID: 27587624.
      Citations: 5     Fields:    Translation:Humans
    197. Castillo JJ, Gustine JN, Meid K, Dubeau T, Yang G, Xu L, Hunter ZR, Treon SP. Idelalisib in Waldenstr?m macroglobulinemia: high incidence of hepatotoxicity. Leuk Lymphoma. 2017 04; 58(4):1002-1004. PMID: 27562445.
      Citations: 11     Fields:    Translation:Humans
    198. Gertz MA, Castillo JJ. Secondary malignancies in patients with multiple myeloma, Waldenstr?m macroglobulinemia and monoclonal gammopathy of undetermined significance. Leuk Lymphoma. 2017 04; 58(4):773-780. PMID: 27546465.
      Citations: 10     Fields:    Translation:Humans
    199. Rennke HG, Minnema MC, Kersten MJ, Vos JM, Gustine J, Hunter Z, Manning RJ, Dubeau TE, Meid K, Treon SP, Castillo JJ. Renal disease related to Waldenstr?m macroglobulinaemia: incidence, pathology and clinical outcomes. Br J Haematol. 2016 Nov; 175(4):623-630. PMID: 27468978.
      Citations: 23     Fields:    Translation:Humans
    200. Levin SN, de Gusmao CM, Etherton MR, Will Rondeau M, Meredith DM, Folkerth RD, Klein JP, Nadeem O, Castillo JJ. "All the soarings of my mind begin in my blood:" central nervous system complication of Waldenstr?m macroglobulinemia. Am J Hematol. 2016 Oct; 91(10):1057-60. PMID: 27414991.
      Citations:    Fields:    Translation:Humans
    201. Castillo JJ, Glezerman IG, Boklage SH, Chiodo J, Tidwell BA, Lamerato LE, Schulman KL. The occurrence of hyponatremia and its importance as a prognostic factor in a cross-section of cancer patients. BMC Cancer. 2016 07 29; 16:564. PMID: 27473121; PMCID: PMC4966824.
      Citations:    
    202. Olszewski AJ, Treon SP, Castillo JJ. Evolution of Management and Outcomes in Waldenstr?m Macroglobulinemia: A Population-Based Analysis. Oncologist. 2016 Nov; 21(11):1377-1386. PMID: 27473042; PMCID: PMC5189618.
      Citations: 15     Fields:    
    203. Castillo JJ, Gustine J, Meid K, Dubeau T, Hunter ZR, Treon SP. Histological transformation to diffuse large B-cell lymphoma in patients with Waldenstr?m macroglobulinemia. Am J Hematol. 2016 10; 91(10):1032-5. PMID: 27415417.
      Citations: 16     Fields:    Translation:Humans
    204. Leblond V, Kastritis E, Advani R, Ansell SM, Buske C, Castillo JJ, Garc?a-Sanz R, Gertz M, Kimby E, Kyriakou C, Merlini G, Minnema MC, Morel P, Morra E, Rummel M, Wechalekar A, Patterson CJ, Treon SP, Dimopoulos MA. Treatment recommendations from the Eighth International Workshop on Waldenstr?m's Macroglobulinemia. Blood. 2016 09 08; 128(10):1321-8. PMID: 27432877.
      Citations:    
    205. Mason C, Savona S, Rini JN, Castillo JJ, Xu L, Hunter ZR, Treon SP, Allen SL. Ibrutinib penetrates the blood brain barrier and shows efficacy in the therapy of Bing Neel syndrome. Br J Haematol. 2017 10; 179(2):339-341. PMID: 27409073.
      Citations: 21     Fields:    Translation:Humans
    206. Olszewski AJ, Fallah J, Castillo JJ. Human immunodeficiency virus-associated lymphomas in the antiretroviral therapy era: Analysis of the National Cancer Data Base. Cancer. 2016 09 01; 122(17):2689-97. PMID: 27337679.
      Citations: 17     Fields:    Translation:Humans
    207. Anderson KC, Munshi NM, Hunter ZR, Xu L, Yang G, Tsakmaklis N, Vos JM, Liu X, Chen J, Manning RJ, Chen JG, Brodsky P, Patterson CJ, Gustine J, Dubeau T, Castillo JJ, Treon SP. Transcriptome sequencing reveals a profile that corresponds to genomic variants in Waldenstr?m macroglobulinemia. Blood. 2016 08 11; 128(6):827-38. PMID: 27301862; PMCID: PMC4982454.
      Citations: 38     Fields:    Translation:HumansCells
    208. Palomba ML, Advani R, Castillo JJ, Treon SP. Ibrutinib in Waldenstr?m macroglobulinemia: latest evidence and clinical experience. Ther Adv Hematol. 2016 Aug; 7(4):179-86. PMID: 27493708; PMCID: PMC4959643.
      Citations: 11     
    209. Yang G, Buhrlage SJ, Tan L, Liu X, Chen J, Xu L, Tsakmaklis N, Chen JG, Patterson CJ, Brown JR, Castillo JJ, Zhang W, Zhang X, Liu S, Cohen P, Hunter ZR, Gray N, Treon SP. HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib. Blood. 2016 06 23; 127(25):3237-52. PMID: 27143257.
      Citations: 46     Fields:    Translation:HumansCells
    210. Castillo JJ, Marini C, Baldaia H, Trigo F. Transformation of a previously diagnosed diffuse large B-cell lymphoma to plasmablastic lymphoma. Am J Hematol. 2016 Aug; 91(8):E324. PMID: 27012155.
      Citations: 2     Fields:    Translation:HumansCells
    211. Castillo JJ, Beltran BE, Miranda RN, Young KH, Chavez JC, Sotomayor EM. EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management. Am J Hematol. 2016 May; 91(5):529-37. PMID: 27093913.
      Citations: 28     Fields:    Translation:HumansAnimalsCells
    212. Gustine JN, Meid K, Dubeau TE, Treon SP, Castillo JJ. Atrial fibrillation associated with ibrutinib in Waldenstr?m macroglobulinemia. Am J Hematol. 2016 06; 91(6):E312-3. PMID: 26994323.
      Citations: 12     Fields:    Translation:HumansCTClinical Trials
    213. Jurczyszyn A, Grzasko N, Gozzetti A, Czepiel J, Cerase A, Hungria V, Crusoe E, Silva Dias AL, Vij R, Fiala MA, Caers J, Rasche L, Nooka AK, Lonial S, Vesole DH, Philip S, Gangatharan S, Druzd-Sitek A, Walewski J, Corso A, Cocito F, Vekemans MC, Atilla E, Beksac M, Leleu X, Davila J, Badros A, Aneja E, Abildgaard N, Kastritis E, Fantl D, Schutz N, Pika T, Butrym A, Olszewska-Szopa M, Usnarska-Zubkiewicz L, Usmani SZ, Nahi H, Chim CS, Shustik C, Madry K, Lentzsch S, Swiderska A, Helbig G, Guzicka-Kazimierczak R, Lendvai N, Waage A, Andersen KT, Murakami H, Zweegman S, Castillo JJ. Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice. Am J Hematol. 2016 06; 91(6):575-80. PMID: 26955792; PMCID: PMC5502095.
      Citations: 33     Fields:    Translation:Humans
    214. Liu X, Hunter ZR, Xu L, Chen J, Chen JG, Tsakmaklis N, Patterson CJ, Castillo JJ, Buhrlage S, Gray N, Treon SP, Yang G. Targeting Myddosome Assembly in Waldenstrom Macroglobulinaemia. Br J Haematol. 2017 06; 177(5):808-813. PMID: 27073043.
      Citations: 7     Fields:    Translation:HumansCells
    215. Castillo JJ, Ghobrial IM, Treon SP. Response to ibrutinib in a patient with IgG lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation. Leuk Lymphoma. 2016 11; 57(11):2699-701. PMID: 26980069.
      Citations: 3     Fields:    Translation:Humans
    216. Olszewski AJ, Castillo JJ. Outcomes of HIV-associated Hodgkin lymphoma in the era of antiretroviral therapy. AIDS. 2016 Mar 13; 30(5):787-96. PMID: 26730566.
      Citations: 8     Fields:    Translation:Humans
    217. Gustine J, Meid K, Xu L, Hunter ZR, Castillo JJ, Treon SP. To select or not to select? The role of B-cell selection in determining the MYD88 mutation status in Waldenstr?m Macroglobulinaemia. Br J Haematol. 2017 03; 176(5):822-824. PMID: 26936399.
      Citations: 11     Fields:    Translation:HumansCells
    218. Roccaro AM, Sacco A, Shi J, Chiarini M, Perilla-Glen A, Manier S, Glavey S, Aljawai Y, Mishima Y, Kawano Y, Moschetta M, Correll M, Improgo MR, Brown JR, Imberti L, Rossi G, Castillo JJ, Treon SP, Freedman ML, Van Allen EM, Hide W, Hiller E, Rainville I, Ghobrial IM. Exome sequencing reveals recurrent germ line variants in patients with familial Waldenstr?m macroglobulinemia. Blood. 2016 05 26; 127(21):2598-606. PMID: 26903547.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    219. Olszewski AJ, Falah J, Castillo JJ. Survival Claims From Observational Data on Cancer Therapy. J Clin Oncol. 2016 Apr 20; 34(12):1425-7. PMID: 26884574.
      Citations: 2     Fields:    Translation:Humans
    220. Jurczyszyn A, Olszewska-Szopa M, Hungria V, Crusoe E, Pika T, Delforge M, Leleu X, Rasche L, Nooka AK, Druzd-Sitek A, Walewski J, Davila J, Caers J, Maisnar V, Gertz M, Gentile M, Fantl D, Mele G, Vesole DH, Yee AJ, Shustik C, Lentzsch S, Zweegman S, Gozzetti A, Skotnicki AB, Castillo JJ. Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients. Leuk Lymphoma. 2016 09; 57(9):2071-6. PMID: 26726867.
      Citations: 15     Fields:    Translation:Humans
    221. Treon SP, Davids MS, Castillo JJ. Inhibition of the Bruton Tyrosine Kinase Pathway in B-Cell Lymphoproliferative Disorders. Cancer J. 2016 Jan-Feb; 22(1):34-9. PMID: 26841015.
      Citations: 9     Fields:    Translation:HumansCells
    222. Castillo JJ, D'Sa S, Lunn MP, Minnema MC, Tedeschi A, Lansigan F, Palomba ML, Varettoni M, Garcia-Sanz R, Nayak L, Lee EQ, Rinne ML, Norden AD, Ghobrial IM, Treon SP. Central nervous system involvement by Waldenstr?m macroglobulinaemia (Bing-Neel syndrome): a multi-institutional retrospective study. Br J Haematol. 2016 Mar; 172(5):709-15. PMID: 26686858; PMCID: PMC5480405.
      Citations: 20     Fields:    Translation:Humans
    223. Castillo JJ, Mulkey F, Geyer S, Kolitz JE, Blum W, Powell BL, George SL, Larson RA, Stone RM. Relationship between obesity and clinical outcome in adults with acute myeloid leukemia: A pooled analysis from four CALGB (alliance) clinical trials. Am J Hematol. 2016 Feb; 91(2):199-204. PMID: 26526191; PMCID: PMC4724329.
      Citations: 17     Fields:    Translation:Humans
    224. Castillo JJ, Kanan S, Meid K, Manning R, Hunter ZR, Treon SP. Rituximab intolerance in patients with Waldenstr?m macroglobulinaemia. Br J Haematol. 2016 08; 174(4):645-8. PMID: 26523929.
      Citations: 14     Fields:    Translation:Humans
    225. Rodr?guez H, Levican J, Mu?oz JP, Carrillo D, Acevedo ML, Gaggero A, Le?n O, Gheit T, Espinoza-Navarro O, Castillo J, Gallegos I, Tommasino M, Aguayo F. Viral infections in prostate carcinomas in Chilean patients. Infect Agent Cancer. 2015; 10:27. PMID: 26330890; PMCID: PMC4556319.
      Citations:    
    226. Beltran BE, Aguilar C, Morales D, Chavez JC, Sotomayor EM, Castillo JJ, Qui?ones P. The neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with peripheral T-cell lymphoma, unspecified. Leuk Lymphoma. 2016; 57(1):58-62. PMID: 25926063.
      Citations: 13     Fields:    Translation:HumansCells
    227. Olszewski AJ, Winer ES, Castillo JJ. Validation of clinical prognostic indices for diffuse large B-cell lymphoma in the National Cancer Data Base. Cancer Causes Control. 2015 Aug; 26(8):1163-72. PMID: 26054914.
      Citations: 10     Fields:    Translation:Humans
    228. Olszewski AJ, Castillo JJ, Kanan S, Meid K, Hunter ZR, Treon SP. Survival outcomes of secondary cancers in patients with Waldenstr?m macroglobulinemia: An analysis of the SEER database. Am J Hematol. 2015 Aug; 90(8):696-701. PMID: 25963924.
      Citations: 4     Fields:    Translation:Humans
    229. Leblebjian H, Noonan K, Paba-Prada C, Treon SP, Castillo JJ, Ghobrial IM. Cyclophosphamide, bortezomib, and dexamethasone combination in waldenstrom macroglobulinemia. Am J Hematol. 2015 Jun; 90(6):E122-3. PMID: 25703132.
      Citations: 3     Fields:    Translation:Humans
    230. Reagan JL, Sullivan MR, Winer ES, Lansigan F, Cardin MS, Castillo JJ. Potential for improved survival with intensification of daunorubicin based induction chemotherapy in acute myeloid leukemia patients who do not receive transplant: A multicenter retrospective study. Leuk Res. 2015 Aug; 39(8):812-7. PMID: 26045177.
      Citations: 1     Fields:    Translation:Humans
    231. Tripsas CK, Meid K, Warren D, Varma G, Green R, Argyropoulos KV, Yang G, Cao Y, Xu L, Patterson CJ, Rodig S, Zehnder JL, Aster JC, Harris NL, Kanan S, Ghobrial I, Castillo JJ, Laubach JP, Hunter ZR, Salman Z, Li J, Cheng M, Clow F, Graef T, Palomba ML, Advani RH, Treon SP. Ibrutinib in previously treated Waldenstr?m's macroglobulinemia. N Engl J Med. 2015 Apr 09; 372(15):1430-40. PMID: 25853747.
      Citations: 280     Fields:    Translation:HumansCTClinical Trials
    232. Castillo JJ, Olszewski AJ, Hunter ZR, Kanan S, Meid K, Treon SP. Incidence of secondary malignancies among patients with Waldenstr?m macroglobulinemia: An analysis of the SEER database. Cancer. 2015 Jul 01; 121(13):2230-6. PMID: 25757851.
      Citations:    
    233. Garg M, Lee BE, McGarry K, Mangray S, Castillo JJ. CD20-negative diffuse large B-cell lymphoma presenting with lactic acidosis. Am J Hematol. 2015 Mar; 90(3):E49-50. PMID: 25417998.
      Citations: 5     Fields:    Translation:HumansCells
    234. Castillo JJ, Chavez JC, Hernandez-Ilizaliturri FJ, Montes-Moreno S. CD20-negative diffuse large B-cell lymphomas: biology and emerging therapeutic options. Expert Rev Hematol. 2015 Jun; 8(3):343-54. PMID: 25641215.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    235. Castillo JJ, Bibas M, Miranda RN. The biology and treatment of plasmablastic lymphoma. Blood. 2015 Apr 09; 125(15):2323-30. PMID: 25636338.
      Citations: 125     Fields:    Translation:HumansAnimalsCells
    236. Castillo JJ, Reagan JL, Sikov WM, Winer ES. Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic lymphoma. Br J Haematol. 2015 May; 169(3):352-5. PMID: 25612847.
      Citations: 32     Fields:    Translation:Humans
    237. Cao Y, Yang G, Hunter ZR, Liu X, Xu L, Chen J, Tsakmaklis N, Hatjiharissi E, Kanan S, Davids MS, Castillo JJ, Treon SP. The BCL2 antagonist ABT-199 triggers apoptosis, and augments ibrutinib and idelalisib mediated cytotoxicity in CXCR4 Wild-type and CXCR4 WHIM mutated Waldenstrom macroglobulinaemia cells. Br J Haematol. 2015 Jul; 170(1):134-8. PMID: 25582069.
      Citations: 34     Fields:    Translation:Humans
    238. Olszewski AJ, Shrestha R, Castillo JJ. Treatment selection and outcomes in early-stage classical Hodgkin lymphoma: analysis of the National Cancer Data Base. J Clin Oncol. 2015 Feb 20; 33(6):625-33. PMID: 25584010.
      Citations: 27     Fields:    Translation:Humans
    239. Castillo JJ, Ghobrial IM, Treon SP. Biology, prognosis, and therapy of Waldenstr?m Macroglobulinemia. Cancer Treat Res. 2015; 165:177-95. PMID: 25655610.
      Citations: 6     Fields:    Translation:Humans
    240. Jurczyszyn A, Czepiel J, Gdula-Argasinska J, Pasko P, Czapkiewicz A, Librowski T, Perucki W, Butrym A, Castillo JJ, Skotnicki AB. Plasma fatty acid profile in multiple myeloma patients. Leuk Res. 2015 Apr; 39(4):400-5. PMID: 25666255.
      Citations: 10     Fields:    Translation:Humans
    241. Olszewski AJ, Kanan S, Meid K, Hunter ZR, Treon SP, Castillo JJ. Overall survival and competing risks of death in patients with?Waldenstr?m macroglobulinaemia: an analysis of the Surveillance, Epidemiology and End Results database. Br J Haematol. 2015 Apr; 169(1):81-9. PMID: 25521528.
      Citations: 28     Fields:    Translation:Humans
    242. Banwait R, Aljawai Y, Cappuccio J, McDiarmid S, Morgan EA, Leblebjian H, Roccaro AM, Laubach J, Castillo JJ, Paba-Prada C, Treon S, Redd R, Weller E, Ghobrial IM. Extramedullary Waldenstr?m macroglobulinemia. Am J Hematol. 2015 Feb; 90(2):100-4. PMID: 25349134.
      Citations: 14     Fields:    Translation:HumansCells
    243. Cao Y, Hunter ZR, Liu X, Xu L, Yang G, Chen J, Tsakmaklis N, Kanan S, Castillo JJ, Treon SP. CXCR4 WHIM-like frameshift and nonsense mutations promote ibrutinib resistance but do not supplant MYD88(L265P) -directed survival signalling in Waldenstr?m macroglobulinaemia cells. Br J Haematol. 2015 Mar; 168(5):701-7. PMID: 25371371.
      Citations: 36     Fields:    Translation:HumansCells
    244. Castillo JJ, Morales D, Paredes A, Nieto G, Miranda RN, Torres-Cabala CA, Beltr?n BE, Qui?ones P. Extranodal marginal zone lymphoma from ocular adnexae with subcutaneous involvement. Am J Dermatopathol. 2014 Nov; 36(11):e189-93. PMID: 25238445.
      Citations:    Fields:    Translation:Humans
    245. Bibas M, Castillo JJ. Current knowledge on HIV-associated Plasmablastic Lymphoma. Mediterr J Hematol Infect Dis. 2014; 6(1):e2014064. PMID: 25408850; PMCID: PMC4235470.
      Citations:    
    246. Vasquez L, Morales D, Paredes G, Miranda RN, Castillo JJ, Beltr?n BE, Maza I, Mois?s-Alfaro CB, Qui?ones P, S?nchez G, Oscanoa M, Ger?nimo J. Thalidomide for the treatment of hydroa vacciniforme-like lymphoma: report of four pediatric cases from Peru. Am J Hematol. 2014 Dec; 89(12):1160-1. PMID: 25196949.
      Citations: 7     Fields:    Translation:Humans
    247. Castillo JJ, Bower M, Novak U, Furrer H, Tanaka PY, Besson C, Montoto S, Cwynarski K, Abramson JS, Dalia S, Bibas M, Connors JM, Furman M, Nguyen ML, Cooley TP, Beltran BE, Collins JA, Vose JM, Xicoy B, Ribera JM, HIV-Associated Hodgkin Lymphoma in the cART Era Study Group, Br?hlmann J. Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study. Cancer. 2015 Feb 01; 121(3):423-31. PMID: 25251326.
      Citations: 9     Fields:    Translation:Humans
    248. Aguilar C, Beltran B, Carbajal T, Vilcapaza J, Yabar A, Segura P, Miranda RN, Castillo JJ, Qui?ones P, Quintanilla-Martinez L. Large B-cell lymphoma arising in cardiac myxoma or intracardiac fibrinous mass: a localized lymphoma usually associated with Epstein-Barr virus? Cardiovasc Pathol. 2015 Jan-Feb; 24(1):60-4. PMID: 25307939.
      Citations: 11     Fields:    Translation:Humans
    249. Petrich AM, Gandhi M, Jovanovic B, Castillo JJ, Rajguru S, Yang DT, Shah KA, Whyman JD, Lansigan F, Hernandez-Ilizaliturri FJ, Lee LX, Barta SK, Melinamani S, Karmali R, Adeimy C, Smith S, Dalal N, Nabhan C, Peace D, Vose J, Evens AM, Shah N, Fenske TS, Zelenetz AD, Landsburg DJ, Howlett C, Mato A, Jaglal M, Chavez JC, Tsai JP, Reddy N, Li S, Handler C, Flowers CR, Cohen JB, Blum KA, Song K, Sun HL, Press O, Cassaday R, Jaso J, Medeiros LJ, Sohani AR, Abramson JS. Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis. Blood. 2014 Oct 09; 124(15):2354-61. PMID: 25161267.
      Citations: 131     Fields:    Translation:Humans
    250. Jurczyszyn A, Czepiel J, Gdula-Argasinska J, Czapkiewicz A, Biesiada G, Dr?zdz M, Perucki W, Castillo JJ. Erythrocyte membrane fatty acids in multiple myeloma patients. Leuk Res. 2014 Oct; 38(10):1260-5. PMID: 25192858.
      Citations:    
    251. Merlini G, Treon SP, Hunter ZR, Castillo JJ. Waldenstr?m macroglobulinemia. Hematol Oncol Clin North Am. 2014 Oct; 28(5):945-70. PMID: 25212891.
      Citations: 5     Fields:    Translation:HumansCells
    252. Apor E, O'Brien J, Stephen M, Castillo JJ. Systemic lupus erythematosus is associated with increased incidence of hematologic malignancies: a meta-analysis of prospective cohort studies. Leuk Res. 2014 Sep; 38(9):1067-71. PMID: 25052307.
      Citations: 6     Fields:    Translation:Humans
    253. Olszewski AJ, Cronin AM, Castillo JJ, Hunter ZR, Treon SP. Survival trends in Waldenstr?m macroglobulinemia: an analysis of the Surveillance, Epidemiology and End Results database. Blood. 2014 Jun 19; 123(25):3999-4000. PMID: 24948623.
      Citations: 22     Fields:    Translation:Humans
    254. Al-Malki MM, Castillo JJ, Sloan JM, Re A. Hematopoietic cell transplantation for plasmablastic lymphoma: a review. Biol Blood Marrow Transplant. 2014 Dec; 20(12):1877-84. PMID: 24946718.
      Citations: 28     Fields:    Translation:Humans
    255. Turnbull B, Treon SP, Tripsas CK, Meid K, Kanan S, Sheehy P, Chuma S, Xu L, Cao Y, Yang G, Liu X, Patterson CJ, Warren D, Hunter ZR, Ghobrial IM, Castillo JJ. Carfilzomib, rituximab, and dexamethasone (CaRD) treatment offers a neuropathy-sparing approach for treating Waldenstr?m's macroglobulinemia. Blood. 2014 Jul 24; 124(4):503-10. PMID: 24859363.
      Citations: 41     Fields:    Translation:HumansCTClinical Trials
    256. Fircanis S, Merriam P, Khan N, Castillo JJ. The relation between cigarette smoking and risk of acute myeloid leukemia: an updated meta-analysis of epidemiological studies. Am J Hematol. 2014 Aug; 89(8):E125-32. PMID: 24753145.
      Citations: 33     Fields:    Translation:Humans
    257. Olszewski AJ, Winer ES, Castillo JJ. Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell lymphoma. Leuk Res. 2014 Aug; 38(8):866-73. PMID: 24837081.
      Citations: 7     Fields:    Translation:Humans
    258. Reagan JL, Castillo JJ. Ofatumumab as front-line therapy in untreated chronic lymphocytic leukemia. Future Oncol. 2014 May; 10(7):1147-55. PMID: 24947256.
      Citations: 2     Fields:    Translation:HumansAnimals
    259. Gavini A, Reagan JL, Winer ES, Castillo JJ. Primary refractory Hodgkin lymphoma: limited options and poor survival--but not always. Am J Hematol. 2014 Aug; 89(8):853-7. PMID: 24382755.
      Citations:    Fields:    Translation:Humans
    260. Castillo JJ, Iyengar M, Kuritzky B, Bishop KD. Isotype-specific inhibition of the phosphatidylinositol-3-kinase pathway in hematologic malignancies. Onco Targets Ther. 2014; 7:333-42. PMID: 24591840; PMCID: PMC3937185.
      Citations:    
    261. Castillo JJ, Winer ES, Olszewski AJ. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database. Am J Hematol. 2014 Mar; 89(3):310-4. PMID: 24273125.
      Citations: 49     Fields:    Translation:Humans
    262. Castillo JJ, Reagan JL, Bishop KD, Apor E. Viral lymphomagenesis: from pathophysiology to the rationale for novel therapies. Br J Haematol. 2014 May; 165(3):300-15. PMID: 24533596.
      Citations: 5     Fields:    Translation:HumansAnimalsCells
    263. Castillo JJ, Nadeem O. Improving the accuracy in prognosis for Burkitt lymphoma patients. Expert Rev Anticancer Ther. 2014 Feb; 14(2):125-7. PMID: 24329420.
      Citations:    
    264. Miranda RN, Aladily TN, Prince HM, Kanagal-Shamanna R, de Jong D, Fayad LE, Amin MB, Haideri N, Bhagat G, Brooks GS, Shifrin DA, O'Malley DP, Cheah CY, Bacchi CE, Gualco G, Li S, Keech JA, Hochberg EP, Carty MJ, Hanson SE, Mustafa E, Sanchez S, Manning JT, Xu-Monette ZY, Miranda AR, Fox P, Bassett RL, Castillo JJ, Beltran BE, de Boer JP, Chakhachiro Z, Ye D, Clark D, Young KH, Medeiros LJ. Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients. J Clin Oncol. 2014 Jan 10; 32(2):114-20. PMID: 24323027; PMCID: PMC4062709.
      Citations: 96     Fields:    Translation:Humans
    265. Castillo JJ, Ingham RR, Reagan JL, Furman M, Dalia S, Mitri J. Obesity is associated with increased relative risk of diffuse large B-cell lymphoma: a meta-analysis of observational studies. Clin Lymphoma Myeloma Leuk. 2014 Apr; 14(2):122-30. PMID: 24360912.
      Citations: 9     Fields:    Translation:Humans
    266. Castillo JJ, Winer ES, Olszewski AJ. Population-based prognostic factors for survival in patients with Burkitt lymphoma: an analysis from the Surveillance, Epidemiology, and End Results database. Cancer. 2013 Oct 15; 119(20):3672-9. PMID: 23913575.
      Citations: 19     Fields:    Translation:Humans
    267. Dalia S, Chavez J, Castillo JJ, Sokol L. Hepatitis B infection increases the risk of non-Hodgkin lymphoma: a meta-analysis of observational studies. Leuk Res. 2013 Sep; 37(9):1107-15. PMID: 23809055.
      Citations: 34     Fields:    Translation:HumansCells
    268. Beltran BE, Morales D, Alva JC, Miranda RN, Lu G, Shah BD, Sotomayor EM, Castillo JJ, Qui?ones P. Follicular lymphoma with leukemic phase at diagnosis: a series of seven cases and review of the literature. Leuk Res. 2013 Sep; 37(9):1116-9. PMID: 23790442; PMCID: PMC4038155.
      Citations: 7     Fields:    Translation:Humans
    269. Reagan JL, Fast LD, Safran H, Nevola M, Winer ES, Castillo JJ, Butera JN, Quesenberry MI, Young CT, Quesenberry PJ. Cellular immunotherapy for refractory hematological malignancies. J Transl Med. 2013 Jun 19; 11:150. PMID: 23782682; PMCID: PMC3689050.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    270. Kuritzky B, Morales D, Lu G, Goswami M, Miranda RN, Castillo JJ, Beltr?n BE, Qui?ones P, Alva JC. Extranodal marginal zone lymphoma of the cranial dura mater: report of three cases and systematic review of the literature. Leuk Lymphoma. 2013 Oct; 54(10):2306-9. PMID: 23363270.
      Citations: 3     Fields:    Translation:HumansCells
    271. Castillo JJ, Sinclair N, Song MK, Ilic I, Leppa S, Nurmi H, Seki R, Uccella S, Li JM, Treaba DO, Stachurski D, Butera JN, Beltr?n BE. Similar outcomes in Asian and Western patients with diffuse large B-cell lymphoma treated with R-CHOP. Leuk Res. 2013 Apr; 37(4):386-91. PMID: 23352640.
      Citations: 4     Fields:    Translation:Humans
    272. Nakhla PS, Butera JN, Treaba DO, Castillo JJ, Quesenberry PJ. Spontaneous regression of chronic lymphocytic leukemia to a monoclonal B-lymphocytosis or to a normal phenotype. Leuk Lymphoma. 2013 Aug; 54(8):1647-51. PMID: 23185961.
      Citations: 4     Fields:    Translation:HumansCells
    273. Llau JV, Ferrandis R, Castillo J, de Andr?s J, Gomar C, G?mez-Luque A, Hidalgo F, Torres LM. [Recommendations on use of direct oral anticoagulants in the perioperative period]. Med Clin (Barc). 2012 Oct; 139 Suppl 2:46-50. PMID: 23498073.
      Citations:    
    274. Castillo JJ, Beltran BE. Not all aggressive adult T-cell leukemia/lymphoma subtypes are created equal. J Clin Oncol. 2012 Oct 01; 30(28):3560; author reply 3561. PMID: 22927519.
      Citations:    Fields:    Translation:Humans
    275. Olszewski AJ, Castillo JJ. Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database. Cancer. 2013 Feb 01; 119(3):629-38. PMID: 22893605.
      Citations: 56     Fields:    Translation:Humans
    276. Treaba DO, Khedr S, Mangray S, Jackson C, Castillo JJ, Winer ES. Acute Myeloid Leukemia Evolving from JAK 2-Positive Primary Myelofibrosis and Concomitant CD5-Negative Mantle Cell Lymphoma: A Case Report and Review of the Literature. Case Rep Hematol. 2012; 2012:875039. PMID: 22953080; PMCID: PMC3420541.
      Citations:    
    277. Castillo JJ, Shum H, Lahijani M, Winer ES, Butera JN. Prognosis in primary effusion lymphoma is associated with the number of body cavities involved. Leuk Lymphoma. 2012 Dec; 53(12):2378-82. PMID: 22591071.
      Citations: 19     Fields:    Translation:HumansCells
    278. Castillo JJ, Vincent M, Justice E. Diagnosis and management of hyponatremia in cancer patients. Oncologist. 2012; 17(6):756-65. PMID: 22618570; PMCID: PMC3380874.
      Citations: 81     Fields:    Translation:Humans
    279. Castillo JJ, Dhami PK, Curry S, Brennan K. No association between cigarette smoking and incidence of plasma cell myeloma: a meta-analysis of 17 observational studies. Am J Hematol. 2012 Jul; 87(7):729-31. PMID: 22566293.
      Citations: 6     Fields:    Translation:Humans
    280. Guti?rrez A, Wiese R, Castillo J, Folino JO. [Evaluation of psychometric characteristics of the Argentinean version of the Hare Psychopathy Checklist: Youth Version]. Vertex. 2012 May-Jun; 23(103):180-7. PMID: 23145372.
      Citations:    
    281. Castillo JJ, Dalia S. Cigarette smoking is associated with a small increase in the incidence of non-Hodgkin lymphoma: a meta-analysis of 24 observational studies. Leuk Lymphoma. 2012 Oct; 53(10):1911-9. PMID: 22397720.
      Citations: 7     Fields:    Translation:Humans
    282. Castillo JJ, Furman M, Bibas M, Bower M, Chen W, Liu JJ, Miranda RN, Montoto S, Nanaji NM, Seegmiller AC, Vose JM, Beltr?n BE, D?ez-Mart?n JL, Navarro JT. Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy. Cancer. 2012 Nov 01; 118(21):5270-7. PMID: 22510767.
      Citations: 44     Fields:    Translation:Humans
    283. Castillo JJ, Mull N, Reagan JL, Nemr S, Mitri J. Increased incidence of non-Hodgkin lymphoma, leukemia, and myeloma in patients with diabetes mellitus type 2: a meta-analysis of observational studies. Blood. 2012 May 24; 119(21):4845-50. PMID: 22496152; PMCID: PMC3367891.
      Citations:    
    284. Reagan JL, Castillo JJ. Why is my patient neutropenic? Hematol Oncol Clin North Am. 2012 Apr; 26(2):253-66, vii. PMID: 22463826.
      Citations: 2     Fields:    Translation:Humans
    285. Beltran BE, Morales D, Quinones P, Miranda RN, Goswami M, Castillo JJ. Peripheral T-cell lymphoma with a regulatory T-cell phenotype: report of a nodal and an extranodal case from Peru. Appl Immunohistochem Mol Morphol. 2012 Mar; 20(2):196-200. PMID: 21836498.
      Citations: 2     Fields:    Translation:HumansCells
    286. Castillo JJ, Echenique IA. Rituximab in combination with chemotherapy versus chemotherapy alone in HIV-associated non-Hodgkin lymphoma: a pooled analysis of 15 prospective studies. Am J Hematol. 2012 Mar; 87(3):330-3. PMID: 22308010.
      Citations: 8     Fields:    Translation:Humans
    287. Winer ES, Ingham RR, Castillo JJ. PCI-32765: a novel Bruton's tyrosine kinase inhibitor for the treatment of lymphoid malignancies. Expert Opin Investig Drugs. 2012 Mar; 21(3):355-61. PMID: 22300471.
      Citations: 14     Fields:    Translation:HumansAnimalsCells
    288. Bishop KD, Castillo JJ. Risk factors associated with Clostridium difficile infection in adult oncology patients with a history of recent hospitalization for febrile neutropenia. Leuk Lymphoma. 2012 Aug; 53(8):1617-9. PMID: 22221036.
      Citations: 9     Fields:    Translation:HumansCells
    289. Castillo JJ, Reagan JL, Ingham RR, Furman M, Dalia S, Merhi B, Nemr S, Zarrabi A, Mitri J. Obesity but not overweight increases the incidence and mortality of leukemia in adults: a meta-analysis of prospective cohort studies. Leuk Res. 2012 Jul; 36(7):868-75. PMID: 22285508.
      Citations: 34     Fields:    Translation:Humans
    290. Castillo JJ, Beltran BE, Song MK, Ilic I, Leppa S, Nurmi H, Seki R, Uccella S, Li JM, Treaba DO, Stachurski D, Butera JN. The Hans algorithm is not prognostic in patients with diffuse large B-cell lymphoma treated with R-CHOP. Leuk Res. 2012 Apr; 36(4):413-7. PMID: 22277681.
      Citations: 20     Fields:    Translation:Humans
    291. Castillo JJ, Furman M, Winer ES. CAL-101: a phosphatidylinositol-3-kinase p110-delta inhibitor for the treatment of lymphoid malignancies. Expert Opin Investig Drugs. 2012 Jan; 21(1):15-22. PMID: 22112004.
      Citations: 30     Fields:    Translation:Humans
    292. Beltran BE, Morales D, Revilla JC, Alva JC, Castillo JJ, Qui?ones P. Diffuse large B-cell lymphoma in human T-lymphotropic virus type 1 carriers. Leuk Res Treatment. 2012; 2012:262363. PMID: 23198156; PMCID: PMC3505915.
      Citations: 5     
    293. Castillo JJ, Dalia S, Shum H. Meta-analysis of the association between cigarette smoking and incidence of Hodgkin's Lymphoma. J Clin Oncol. 2011 Oct 10; 29(29):3900-6. PMID: 21911724.
      Citations: 10     Fields:    Translation:HumansPHPublic Health
    294. Beltran BE, Morales D, Medeiros LJ, Miranda RN, Castillo JJ, Qui?ones P. EBV-positive diffuse large b-cell lymphoma in young immunocompetent individuals. Clin Lymphoma Myeloma Leuk. 2011 Dec; 11(6):512-6. PMID: 21889434.
      Citations: 21     Fields:    Translation:Humans
    295. Beltran BE, Castillo JJ, Morales D, de Mendoza FH, Quinones P, Miranda RN, Gallo A, Lopez-Ilasaca M, Butera JN, Sotomayor EM. EBV-positive diffuse large B-cell lymphoma of the elderly: a case series from Peru. Am J Hematol. 2011 Aug; 86(8):663-7. PMID: 21761432.
      Citations: 19     Fields:    Translation:HumansCells
    296. Castillo JJ, Sinclair N, Stachurski D, Jacobsen ED. Positive HIV ELISA test, autoimmune hemolytic anemia, and generalized lymphadenopathy: a unifying diagnosis. Am J Hematol. 2011 Aug; 86(8):690-3. PMID: 21630306.
      Citations:    Fields:    Translation:HumansCells
    297. Castillo JJ, Winer ES, Stachurski D, Perez K, Jabbour M, Milani C, Colvin GA, Butera JN. HIV-negative plasmablastic lymphoma: not in the mouth. Clin Lymphoma Myeloma Leuk. 2011 Apr; 11(2):185-9. PMID: 21575922.
      Citations: 31     Fields:    Translation:Humans
    298. Castillo JJ, Reagan JL. Plasmablastic lymphoma: a systematic review. ScientificWorldJournal. 2011 Mar 22; 11:687-96. PMID: 21442146; PMCID: PMC5720057.
      Citations: 45     Fields:    Translation:Humans
    299. Castillo JJ, Beltran BE, Bibas M, Bower M, Collins JA, Cwynarski K, Diez-Martin JL, Hernandez-Ilizaliturri F, Horwitz SM, Montoto S, Pantanowitz L, Ribera JM, Vose JM. Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: a multicenter study. Am J Hematol. 2011 Mar; 86(3):256-61. PMID: 21328430.
      Citations: 14     Fields:    Translation:Humans
    300. Reagan JL, Castillo JJ. Ofatumumab for newly diagnosed and relapsed/refractory chronic lymphocytic leukemia. Expert Rev Anticancer Ther. 2011 Feb; 11(2):151-60. PMID: 21342032.
      Citations: 4     Fields:    Translation:Humans
    301. Castillo JJ, Beltran BE, Miranda RN, Paydas S, Winer ES, Butera JN. Epstein-barr virus-positive diffuse large B-cell lymphoma of the elderly: what we know so far. Oncologist. 2011; 16(1):87-96. PMID: 21212426; PMCID: PMC3228047.
      Citations: 23     Fields:    Translation:HumansCells
    302. Berz D, Castillo JJ, Quilliam DN, Colvin G. Pesticides and non-Hodgkin lymphoma: an overview for the clinician. Med Health R I. 2011 Jan; 94(1):10-2. PMID: 21290988.
      Citations:    Fields:    Translation:Humans
    303. Wang CC, Castillo JJ. Management of HIV-associated lymphomas. Med Health R I. 2011 Jan; 94(1):4-6. PMID: 21290986.
      Citations: 1     Fields:    Translation:Humans
    304. Beltran BE, Castillo JJ, Salas R, Morales D, Cotrina E, Miranda RN, Sotomayor EM, Qui?ones P. Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone: report of two cases from South America. Leuk Lymphoma. 2011 Jan; 52(1):153-6. PMID: 21219127.
      Citations: 1     Fields:    Translation:HumansCells
    305. Kuczynski M, Rodr?guez MC, Wiese R, Ruiz V, Dal Bello M, Castillo J, Delucchi G, Biesa J, Folino J. [Mental disorders and working capacity evaluation in psychiatric boards]. Vertex. 2011 Jan-Feb; 22(95):11-8. PMID: 21505642.
      Citations:    
    306. Alduaij A, Butera JN, Treaba D, Castillo J. Complete remission in two cases of adult T-cell leukemia/lymphoma treated with hyper-CVAD: a case report and review of the literature. Clin Lymphoma Myeloma Leuk. 2010 Dec; 10(6):480-3. PMID: 21156467.
      Citations:    
    307. Castillo JJ, Rizack T, Treaba D. Immunophenotypical Switch versus Tumor Heterogeneity in a Patient with HIV-Associated Diffuse Large B-Cell Lymphoma. Patholog Res Int. 2010 Oct 05; 2011:563216. PMID: 21151539; PMCID: PMC2989698.
      Citations: 2     
    308. Castillo JJ, Winer ES, Stachurski D, Perez K, Jabbour M, Milani C, Colvin G, Butera JN. Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma. Leuk Lymphoma. 2010 Nov; 51(11):2047-53. PMID: 20919850.
      Citations: 54     Fields:    Translation:HumansCells
    309. Castillo JJ, Morales D, Quinones P, Cotrina E, Desposorio C, Beltran B. Lymphopenia as a prognostic factor in patients with peripheral T-cell lymphoma, unspecified. Leuk Lymphoma. 2010 Oct; 51(10):1822-8. PMID: 20849388.
      Citations: 14     Fields:    Translation:Humans
    310. Layton JL, Castillo JJ. Non-AIDS defining cancers. Med Health R I. 2010 Oct; 93(10):296-8. PMID: 21284267.
      Citations:    
    311. Rivas-Plata A, Castillo J, Pariona M, Chunga A. Bypass grafts and cell transplant in heart failure with low ejection fraction. Asian Cardiovasc Thorac Ann. 2010 Oct; 18(5):425-9. PMID: 20947595.
      Citations:    
    312. Beltran B, Morales D, Cotrina E, Castillo JJ, Qui?ones P. Different prognostic factors for survival in acute and lymphomatous adult T-cell leukemia/lymphoma. Leuk Res. 2011 Mar; 35(3):334-9. PMID: 20828817.
      Citations: 8     Fields:    Translation:Humans
    313. Castillo JJ, Dalia S, Pascual SK. Association between red blood cell transfusions and development of non-Hodgkin lymphoma: a meta-analysis of observational studies. Blood. 2010 Oct 21; 116(16):2897-907. PMID: 20625008.
      Citations: 23     Fields:    Translation:Humans
    314. Mazzaglia PJ, Strenger R, Castillo JJ. Extramedullary relapse of acute myeloid leukemia in a surgical wound. Leuk Lymphoma. 2011 Mar; 52(3):541-3. PMID: 20593978.
      Citations:    Fields:    Translation:Humans
    315. Perez K, Castillo J, Dezube BJ, Pantanowitz L. Human Immunodeficiency Virus-associated anaplastic large cell lymphoma. Leuk Lymphoma. 2010 Mar; 51(3):430-8. PMID: 20141444.
      Citations:    
    316. Castillo J, Perez K. The role of ofatumumab in the treatment of chronic lymphocytic leukemia resistant to previous therapies. J Blood Med. 2010; 1:1-8. PMID: 22282677; PMCID: PMC3262337.
      Citations:    
    317. Morales D, Beltran B, De Mendoza FH, Riva L, Yabar A, Qui?ones P, Butera JN, Castillo J. Epstein-Barr virus as a prognostic factor in de novo nodal diffuse large B-cell lymphoma. Leuk Lymphoma. 2010 Jan; 51(1):66-72. PMID: 19860616.
      Citations:    
    318. Hebert HD, Butera JN, Castillo J, Mega AE. Are we training our fellows adequately in delivering bad news to patients? A survey of hematology/oncology program directors. J Palliat Med. 2009 Dec; 12(12):1119-24. PMID: 19698025.
      Citations:    
    319. Rizack T, Mega A, Legare R, Castillo J. Management of hematological malignancies during pregnancy. Am J Hematol. 2009 Dec; 84(12):830-41. PMID: 19844988.
      Citations:    
    320. Beltran B, Salas R, Qui?ones P, Morales D, Hurtado F, Cotrina E, Riva L, Castillo J. EBV-positive diffuse large B-cell lymphoma in a human T-lymphotropic virus type 1 carrier. Infect Agent Cancer. 2009 Jul 06; 4:10. PMID: 19580668; PMCID: PMC2713202.
      Citations:    
    321. Castillo J, Perez K, Milani C, Dezube BJ, Pantanowitz L. Peripheral T-cell lymphomas in HIV-infected individuals: a comprehensive review. J HIV Ther. 2009 Jun; 14(2):34-40. PMID: 19839365.
      Citations:    
    322. Milani C, Castillo J. Veltuzumab, an anti-CD20 mAb for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and immune thrombocytopenic purpura. Curr Opin Mol Ther. 2009 Apr; 11(2):200-7. PMID: 19330725.
      Citations:    
    323. Castillo J, Milani C, Mendez-Allwood D. Ofatumumab, a second-generation anti-CD20 monoclonal antibody, for the treatment of lymphoproliferative and autoimmune disorders. Expert Opin Investig Drugs. 2009 Apr; 18(4):491-500. PMID: 19335277.
      Citations:    
    324. Beltran B, Castillo J, Salas R, Qui?ones P, Morales D, Hurtado F, Riva L, Winer E. ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature. J Hematol Oncol. 2009 Feb 27; 2:11. PMID: 19250532; PMCID: PMC2651189.
      Citations:    
    325. Castillo J, Pantanowitz L, Dezube BJ. HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases. Am J Hematol. 2008 Oct; 83(10):804-9. PMID: 18756521.
      Citations:    
    326. Castillo J, Winer E, Quesenberry P. Newer monoclonal antibodies for hematological malignancies. Exp Hematol. 2008 Jul; 36(7):755-68. PMID: 18565392.
      Citations:    
    CASTILLO's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (583)
    Explore
    _
    Co-Authors (2)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _